doi: 10.1161/hh1501.094365
© 2001 American Heart Association, Inc.
Review |
Methods of Detection of Vascular Reactive Species
Nitric Oxide, Superoxide, Hydrogen Peroxide, and Peroxynitrite
From the Department of Anesthesiology and the Center for Free Radical Biology (M.M.T.), University of Alabama at Birmingham, Birmingham, Ala, and the Department of Biochemistry (I.F.), Duke University Medical Center, Durham, NC.
Correspondence to Margaret M. Tarpey, MD, Department of Anesthesiology, University of Alabama at Birmingham, 619 19th St South, Birmingham, AL 35233. E-mail margaret.tarpey{at}ccc.uab.edu
 |
Abstract |
|---|
 Top Abstract IntroductionNitric Oxide DetectionSummary and RecommendationsReferences |
|---|
Abstract— The evanescent nature of reactive oxygen and nitrogen species, the multiple cellular mechanisms evolved to maintain these substances at low (submicromolar) concentrations within the vascular system, and the often multifaceted nature of their reactivities have made measurement of these compounds within the vasculature problematic. This review attempts to provide a critical description of some of the most common approaches to quantification of nitric oxide, superoxide, hydrogen peroxide, and peroxynitrite, with attention to key issues that may influence the utility of a particular assay when adapted for use in vascular cells and tissues.
Key Words: free radical • nitric oxide • superoxide • hydrogen peroxide • peroxynitrite
|
Introduction |
|---|
|
TopAbstractIntroductionNitric Oxide DetectionSummary and RecommendationsReferences |
|---|
Reactive oxygen and nitrogen species play a central role in the maintenance of vascular homeostasis and injury. Nitric oxide (NO)-dependent cell signaling, including endothelial-dependent relaxation, is modulated by both superoxide (O2·-) and superoxide dismutase (SOD), the family of enzymes catalyzing the formation of hydrogen peroxide (H2O2) and molecular oxygen from O2·-.1–4 Alterations in both the rates of formation and extents of scavenging of O2·- have been implicated in vascular dysfunction seen in atherosclerosis, hypertension, diabetes, and chronic nitrate tolerance as well as in postischemic myocardium.5–11 Increased rates of vascular production of O2·- and H2O2 contribute to initiation of proinflammatory events, with transcriptional regulation of the gene expression of vascular cellular adhesion molecule-1 and monocyte chemotactic protein-1 sensitive to changes in cellular oxidant production12,13 as well as to modulation of cell-signaling events.14 Peroxynitrite (ONOO-), the diffusion-limited reaction product of O2·- and NO, although limiting the bioavailability of NO, has been proposed to mediate many of the cytotoxic effects associated with NO because of the multiplicity of its reactions with cellular thiols, lipids, proteins, and DNA.15 In addition to its putative role in pathologic processes,5,16 ONOO- may also serve a physiological function as a cell-signaling molecule.17
Sensitive techniques for the analysis of these reactive species are required for developing better insight into the complex interactions that characterize the roles these substances play in vascular homeostasis. However, measurement of the vascular production of reactive species is difficult for several reasons. For example, low intracellular steady-state concentrations of O2·- occur as a result of the balance between endogenous rates of partial reduction of oxygen to O2·- and scavenging of O2·- by highly efficient cytoplasmic and mitochondrial SODs, resulting in intracellular O2·- concentrations estimated to rarely exceed 1 nmol/L.18 Extracellular release of small proportions of intracellularly formed O2·- may occur via anion channels.19,20 In addition, O2·- formed from plasma membrane–bound oxidases remains at relatively low levels in vascular tissues because of serum and extracellular fluid components, including low molecular weight (LMW) oxidant scavengers and the heparin-binding extracellular (EC)-SOD.3,21–24 Thus, the relatively short half-life (seconds) of reactive species and the efficient and redundant systems that have evolved to scavenge them require that any detection technique must be sensitive enough to effectively compete with these intracellular and extracellular antioxidant components for reaction with the substance in question. Additionally, methods for analysis of reactive species must have intracellular access to faithfully reflect the intracellular situation.
Although not intended to serve as an exhaustive review, this article critically explores commonly used approaches to detect reactive species, with particular attention paid to misconceptions that may limit the usefulness of an assay when adapted for vascular cells and tissues.
|
Nitric Oxide Detection |
|---|
|
TopAbstractIntroductionNitric Oxide DetectionSummary and RecommendationsReferences |
|---|
Electrochemical Detection
Nitric oxide is an electrochemically reactive species that can be oxidized at the surface of a metallic, carbon, or carbon-modified anode. Oxidation of NO proceeds by a 1-electron transfer from NO to the anode, generating a nitrosonium cation (NO+), which is ultimately converted to nitrite (NO2-):
|
|
Current generated from the oxidation of NO is directly proportional to NO concentration, with detection limits of 
10 nmol/L NO. A selective gas-permeable hydrophobic membrane is used to allow diffusion of NO to the electrode surface while limiting access of NO2- and other ionic species. Commercially available electrochemical NO electrodes use Clark-type platinum electrodes (1 to 2 mm diameter) or microelectrodes (30 to 200 µm) comprised of coated metal electrodes or carbon fibers. Electrochemical detection has been used in measurements of NO from cultured cells25 as well as NO released into the coronary effluent of isolated working rat hearts.26 A porphyrinic microsensor has been used to measure vascular NO in humans; however, it is not presently commercially available.27 Additionally, carbon fiber/porphyrinic sensors also readily detect catecholamines, such as dopamine and norepinephrine28; thus, in circumstances in which elevated catecholamines are anticipated, such as single-cell recordings, verification of NO concentrations must be confirmed by another technique.29
Hemoglobin Oxidation
The reaction of oxyhemoglobin (HbO2) with NO to form methemoglobin (metHb) and nitrate (NO3-) serves as the basis of a common method to determine rates of NO production. The rapid reaction of NO and HbO2 (3.7x107 [mol/L]-1 · s-1)30
|
|
ensures that under most conditions, NO will be consumed stoichiometrically. When there is concern that O2·- may compete for NO, the addition of >100 U/mL SOD will increase the effectiveness of this assay as well as limit O2·--dependent redox-cycling of Hb.31 An alternative approach is to simultaneously assay NO and O2·- using both metHb formation and cytochrome c reduction.32
Various spectrophotometric methods have been used to determine rates of NO-dependent formation of metHb. Among the most sensitive is dual-wavelength spectroscopy. By using the wavelength pair 401/410 and a band width of 1 nm, there is a detection limit of 1 nmol/L NO. The change in concentration of metHb is represented by the following equation:
|
|
If there is interference, for example because of tissue hemoproteins absorbing strongly in the Soret region of hemoglobin, wavelength pairs using other absorbance maxima and isosbestic points can be used (eg, 577/590), although sensitivity of the assay is then reduced.
There are several critical elements to assure accuracy of this method in determining rates of NO formation. First, variations in hemoglobin concentration, eg, superfusion experiments, can profoundly affect results. The ratio of the absolute absorbance at the isosbestic point over time will provide a correction factor:
|
|
Second, appropriate controls should be used to ensure that the formation of metHb is attributable to NO and not other oxidants potentially present in samples. In the case of cellular or tissue extracts, NO synthase (NOS) inhibitors should inhibit metHb production. Likewise, absence of an exogenous NO donor should yield diminished rates of metHb formation. An additional concern when NO donors are used is the concomitant generation of NO2-, which can independently oxidize HbO2. When high levels of NO2- are anticipated, the contribution of NO2- to metHb formation must be determined and corrected for.
Third, the pH of incubations should also remain constant over the course of the measurement, because the absorption spectrum of metHb is pH-dependent and the experimental conditions under which NO is released may be altered by fluctuations in pH. Nitrite-mediated oxidation of HbO2 is also pH dependent.
Chemiluminescent Detection of NO
Nitric oxide will react with ozone (O3) to form nitrogen dioxide (NO2), a portion of which is in an excited state. As this NO2 species returns to ground state, light is emitted.
|
|
The rapid rate of reaction of NO with O3 (107 [mol/L]-1 · s-1) and the sensitivity of the chemiluminescent detection of light emitted by NO2* (100 pmol/L) thus allows real-time monitoring of NO formation. Although gaseous NO can be detected in a straightforward manner, much of biologically formed NO will be rapidly oxidized to NO2- and NO3-. To detect these NO metabolites in biological fluids, they must first undergo reduction. This can be achieved with the use of nitrate reductase to reduce NO3- to NO2-, which is then further reduced to NO by reaction with iodide under acidic conditions. An alternative method to detect NO metabolites is to reduce NO2- to NO with acidic vanadium (III) at room temperature. After the return of the chemiluminescent tracing to baseline, the temperature is raised to 90°C, which results in vanadium-dependent reduction of NO3- to NO.33 As with other methods of NO3-/NO2- measurement, appropriate controls must be performed to ensure that determinations are the result of NO metabolism and are not attributable to the presence of preformed substances present in culture media or buffer solutions, gastrointestinal bacterial metabolism, or dietary ingestion of NO2-/NO3-.
Griess Reaction
Nitrite, a stable oxidation product of NO, is measured in a spectrophotometric assay using the Griess reagents, sulfanilamide, HCl, and N-(1-napthyl)-ethylenediamine (NED). To measure total accumulated NO oxidation products, any NO3- must first be reduced to NO2-, most commonly with NADH-dependent nitrate reductase. Because NADH interferes with subsequent spectrophotometric detection of NO2-, excess NADH is removed by LDH-catalyzed reaction with pyruvate.34
The reactions are as follows:
|
The reaction can be monitored at A548 in a standard spectrophotometer, or it can be adapted for a microplate reader using a 550-nm filter. Standard curves are generated using NaNO3- or NaNO2- in the range of 0.1 to 40 µmol/L, with sensitivity of 1 µmol/L. Deproteination of samples can improve detection by elimination of turbidity attributable to precipitate formation in protein-rich specimens. Furthermore, sensitivity can be improved by initial addition of acid and sulfanilamide followed by addition of NED, thus reducing competition of NED for sulfanilic acid and carrying out the reaction at low temperature (4°C) to increase the stability of the diazo product. Appropriate controls must be performed to rule out the contribution of background NO2-/NO3-.
Arginine-Citrulline Conversion
Nitric oxide synthase catalyzes oxidation of the guanidino nitrogen of arginine, resulting in formation of NO and stoichiometric amounts of citrulline. Thus, the net potential of a tissue or cell extract to generate NO can be estimated by rates of formation of citrulline from arginine in the presence of saturating concentrations of NOS cofactors FAD, FMN, NADPH, tetrahydrobiopterin, calcium, and calmodulin (in the case of neuronal and endothelial NOS).35 To initiate the reaction, radiolabeled arginine and cofactors are added to cell or tissue preparations; reactions are terminated by the addition of EDTA pH 5.5 to bind calcium, resulting in enzyme inactivation. Samples are then eluted on a cation exchange column; under these conditions, arginine binds to the exchange resin, whereas the zwitterionic citrulline is collected and measured in a liquid scintillation counter.36
There are several critical controls to ensure that this assay reflects NOS-catalyzed formation of citrulline. Radiolabeled arginine, particularly 3H-arginine, can decompose over time; thus, it is essential to demonstrate that applied arginine is retained on the column. To verify that citrulline is the major radiolabeled compound in the flow-through, thin layer chromatography on silica gel G can be performed using the solvent system CHCl3/CH3OH/NH4OH/H2O (0.5:4.5:2.0:1.0). The Rf values for arginine, ornithine, and citrulline with this system are 0.53, 0.92, and 0.77.37,38 Citrulline recycling can occur via argininosuccinate synthase and argininosuccinase to reform arginine and limit apparent rates of citrulline formation.39 Preparations from liver, a tissue with complete urea cycle activity, can result in production of citrulline via ornithine. To confirm that citrulline production is the result of NOS activity, a competitive NOS inhibitor can be added or NADPH can be omitted from the reaction mixture.
Superoxide Detection
Cytochrome c Reduction
Reduction of ferricytochrome c has been used to measure rates of formation of O2·- by numerous enzymes, tissue extracts, and whole cells. This reaction occurs with a rate constant of 1.5x105 [mol/L]-1 · s-1 at pH 8.5 and room temperature40,41:
|
|
The reaction is followed spectrophotometrically at 550 nm; the extinction coefficient for ferricytochrome c is 0.89x104 [mol/L]-1 · cm-1, whereas the extinction coefficient for ferrocytochrome c is 2.99x104 [mol/L]-1 · cm-1. Therefore, 
Em 550nm=2.1x104 [mol/L]-1 · cm-1.42
There are several precautions when using this reaction to detect O2·-.
First, cytochrome c reduction is nonspecific for O2·-. Tissue extracts contain compounds such as ascorbate and glutathione that can reduce cytochrome c as well as cellular reductases that enzymatically catalyze cytochrome c reduction. Additionally, enzymes such as xanthine oxidase are capable of reducing quinones or redox-active dyes that may also be present and whose reduced forms are capable of directly reducing cytochrome c. Specificity of this reaction for O2·- is achieved in part by the extent of inhibition of cytochrome c reduction by added SOD.43
Second, reduced cytochrome c can be reoxidized by cytochrome oxidases, peroxidases, and oxidants, including H2O2 and ONOO-.44 This reoxidation, by diminishing apparent rates of cytochrome c reduction, will underestimate the rate of O2·- formation. Enzyme inhibitors (10 µmol/L CN for cytochrome oxidase) or scavengers of reactive species (100 U/mL catalase for H2O2 and 10 mmol/L urate for ONOO-) can be added to avoid this pitfall.
Third, to enhance specificity of the assay for O2·-, cytochrome c can be acetylated.45 Acetylation of ferricytochrome c lysine residues decreases direct electron transfer by mitochondrial and microsomal reductases to cytochrome c and from cytochrome c to cytochrome oxidase while preserving the capacity of O2·- to reduce cytochrome c.46 Succinoylation of cytochrome c is more effective in decreasing reduction of cytochrome c by NADPH-cytochrome P-450 reductase or cytochrome b5 and oxidation by cytochrome c oxidase. However, the rate constant for reduction of succinoylated cytochrome c by O2·- is 10% of native cytochrome c, thus requiring higher concentrations of succinoylated cytochrome c.47
Nitroblue Tetrazolium
Nitro-substituted aromatics, such as nitroblue tetrazolium (NBT), can be reduced by O2·- via one-electron transfer reactions. Reduction of NBT chloride, a dication, to diformazan proceeds in 2 steps, yielding the partially reduced (2 e-) monoformazan (NBT+) as a stable intermediate. Superoxide can reduce NBT to the monoformazan (NBT+), whose formation can be monitored spectrophotometrically at 550 to 560 nm: Em=1.5x104 [mol/L]-1·cm-1.
The first step of this reaction occurs through a one-electron process to form the NBT radical (NBT+·):
|
|
The NBT radical undergoes a dismutation reaction with another NBT+·, or it can accept a second electron yielding the monoformazan (NBT+).
|
|
or
|
|
However, the reduction of the dication NBT2+ is not exclusive to O2·-. Numerous other substances including cellular reductases can donate an electron to NBT, forming the NBT radical:
|
|
A complication in the use of this detector molecule then arises when under aerobic conditions NBT radical also reacts with environmental O2 to generate O2·-.
|
|
The O2·- thus artifactually formed can then generate the NBT monoformazan. Importantly, this production of formazan is SOD-inhibitable, revealing that SOD-inhibitable formazan formation does not unambiguously reflect enhanced rates of tissue O2·- production in the absence of NBT.48 Rather, it is also possible that changes in tissue content of various oxidoreductases are responsible for alterations in rates of NBT reduction.
Adrenochrome Formation
Linear rates of oxidation of epinephrine to adrenochrome by O2·- occur at 1 to 5 µmol/L · min-1 and can be monitored spectrophotometrically at 485 to 575 nm using a dual-wavelength spectrophotometer (Em=2.96x103 [mol/L-1 · cm-1) or at 480 nm with a single-wavelength spectrophotometer (Em=4.0x103 [mol/L]-1 · cm-1).49 Because of a limited specificity for O2·-, particularly because of epinephrine auto-oxidation, it is imperative to measure SOD-inhibitable rates of adrenochrome formation.50
Cyanide-Resistant Oxygen Consumption
Mitochondria account for the major portion of cellular oxygen consumption under basal conditions. Thus, when mitochondrial respiration is inhibited by the addition of 10 µmol/L CN, residual oxygen consumption reflects other tissue oxygen–consuming reactions, principally the reduction of oxygen to O2·- and H2O2.51 Cyanide-resistant respiration can also include the oxidation of substrates such as lipids, amino acids, and nucleotides.52,53 Thus, specificity of this approach for measuring the production of reactive oxygen species can be enhanced with the addition of cell-permeant forms of SOD and catalase.
Hydroethidine Oxidation
Hydroethidine (dihydroethidium, HE) is cell permeant and can undergo a two-electron oxidation to form the DNA-binding fluorophore ethidium bromide.54 The reaction is relatively specific for O2·-, with minimal oxidation induced by H2O2, ONOO-, or hypochlorous acid (HOCl). The intracellular oxidation of HE to ethidium by O2·- has been analyzed with flow cytometry,55 and visualization of cells and anatomic regions displaying increased rates of oxidant production with digital imaging microfluorometry has been described.56 In contrast to other intracellular probes for O2·-, such as lucigenin (Luc2+) or NBT, there is little capacity for artifactual formation of O2·- by HE attributable to redox cycling. However, there are two critical reactions that may limit the use of HE conversion to ethidium as a quantitative marker for O2·- production.54 First, cytochrome c is also capable of oxidizing HE. This may be of importance when mitochondria are the primary source of O2·- production or when cytochrome c is released into the cytosol under conditions leading to apoptosis.57 Because oxidant stress has been suggested to initiate apoptotic processes and apoptosis itself has been proposed to increase mitochondrial O2·- production,58 it would be difficult to ascribe HE conversion to ethidium solely to O2·-; thus, localization of cellular sites of O2·- generation would be suspect under these circumstances. Second, quantitation of O2·- production using HE will be inaccurate because of its capacity to enhance rates of O2·- dismutation to H2O2.54 Thus, under these conditions, initial rates of O2·- formation will be underestimated.
Electrochemical Detection
There have been several methods reported for the electrochemical detection of O2·-. These include direct oxidation of O2·- on a carbon microfiber microelectrode with an Ag counter-electrode, used to detect O2·- release from single neutrophils.59 A carbon microelectrode covered by a polypyrrole/horseradish peroxidase (HRP) membrane with an additional adsorbed layer of SOD has been described; O2·- is dismuted to H2O2, which is then reduced by HRP, resulting in oxidation at the electrode surface.60 In a somewhat similar fashion, a Clark-type platinum microelectrode has been coated with a polypyrrole film in which SOD is immobilized; the H2O2 generated from the dismutation of O2·- becomes oxidized at the electrode surface.61 However, systems that depend on formation of H2O2 would be unable by themselves to discriminate between processes that primarily form O2·- and those that are directly linked to H2O2 generation. Presently, there are no commercially available electrochemical detection O2·- systems. The ability to use microelectrodes and to image real-time fluxes of O2·- would represent a noteworthy advance in our capacity to understand the significance of oxidant biology.
Electron Spin Resonance and Spin Trapping
The only analytical approach that permits the direct detection of free radicals is electron spin resonance (ESR), also termed electron paramagnetic resonance spectroscopy. This sister technique to nuclear magnetic resonance spectroscopy reports on the magnetic properties of unpaired electrons and their molecular environment. These unpaired electrons can exist in two orientations, either parallel or antiparallel with respect to an applied magnetic field. The energy differences of these states correspond to the microwave region of the electromagnetic spectrum. Although unpaired electrons of species such as NO, ·OH, or O2·- are too low in concentration and short-lived to be directly detected by ESR in biological systems, this dilemma can be circumvented by ESR measurement of more stable secondary radical species formed by adding exogenous spin-traps—molecules that react with primary radical species to give longer-lasting radical adducts with characteristic ESR signatures that can accumulate to levels permitting detection. These spin traps, frequently nitroxide and nitrone derivatives, can also be used to label biomolecules and probe basal and oxidation-induced events in protein and lipid microenvironments.62 Interestingly, this spin-trap approach can also be used to measure tissue oxygen consumption and to noninvasively spatially map oxygen concentrations in living tissues.63,64 With a sensitivity limit of 10-9 mol/L, ESR spectroscopy is also capable of detecting the more stable free radical–derived species produced in the vascular compartment during oxidative and inflammatory injury, including ascorbyl radical, tocopheroxyl radical, and heme-nitrosyl complexes.65 The use of spin traps such as phenyl-tert-butylnitrone (PBN) and 5,5-dimethylpyrroline-N-oxide (DMPO) has had an illustrious history in detecting organic radical products of lipid peroxidation (PBN), ·OH, and O2·- (DMPO). However, uncertainties about influences on NO metabolism (PBN) and the ability of ferric ion to oxidize DMPO resulting in the classic 4-line spectrum associated with ·OH metabolism66 have led to development of more selective species. More recently, a more O2·--specific and stable spin trap, 5-diethoxyphosphoryl-5-methyl-1-pyrroline-N-oxide (DEPMPO),67,68 has proven increasingly useful in measuring extents of cell and tissue O2·- production.69,70 Reaction of NO with endogenous heme and nonheme iron proteins leads to formation of iron-nitrosyl complexes with characteristic spectra.71–73 Addition of exogenous iron-dithiocarbamates and nitronyl nitroxides has also been used to detect NO formation.74 Both reactive oxygen species and NO have been detected in vivo with ESR.75,76 Although instability, tissue metabolism, the sometimes broad reactivity of spin traps, and the cost of ESR spectrometers can be problematic, when combined with parallel strategies for detecting specific reactive species, ESR has proven to be a useful and revealing free radical detection strategy.
Chemiluminescence Reactions
Chemiluminescent methods of O2·- detection in vascular tissues have been used frequently because of the potential for access to intracellular sites of O2·- generation, the alleged specificity of reaction of the probe with O2·-, minimal cellular toxicity, and purported increased sensitivity compared with chemical measurements. Several compounds have been used for chemiluminescent detection of O2·-, including Luc2+, luminol (LumH2), and coelenterazine [2-(4-hydroxybenzyl)-6-(4-hydroxyphenyl)-8-benzyl-3,7-dihydroimidazo [1,2-
]pyrazin-3-one] and its analogs CLA (2-methyl-6-phenyl-3,7-dihydroimidazo[1,2-]pyrazin-3-one) and MCLA [2-methyl-6-(4-methoxyphenyl)-3,7-dihydroimidazo[1,2-]pyrazin-3-one].77–79
Lucigenin and LumH2 and the light they can produce have long been studied in the hope that understanding these chemiluminescences would lead to insight into the mechanism of bioluminescence. Thus, Gleu and Petsch80 knew in 1935 that oxidants such as hypochlorite or ferricyanide would elicit LumH2 luminescence, provided that O2 was also present, but these oxidants did not cause Luc2+ to emit light. In contrast, reductants, such as dithionite or stannite, caused Luc2+ to luminesce aerobically but failed to induce LumH2 luminescence. Hydrogen peroxide, which at elevated pH can act both as a reductant and as an oxidant, was also able to elicit LumH2 luminescence. The mechanism proposed at that time was incorrect, but the observations must be accommodated by any mechanism now espoused.
Totter et al81 noted that the aerobic xanthine oxidase (XO)/hypoxanthine reaction could cause Luc2+ luminescence, and they proposed that O2 radicals were involved in this process.82 Greenlee et al83 then proceeded to study the effect of pO2 on the Luc2+ and LumH2 luminescences in the XO system, and they noted that raising PO2 from 0% to 100% increased the LumH2 luminescence over that entire range but that Luc2+ light production was optimal at 2% O2 and declined at higher [O2]. They also noted that Luc2+ was reduced by XO/xanthine under anaerobic conditions and that a reduction intermediate of Luc2+ was autoxidizable. Moreover, the catechol, tiron, which had already been seen to inhibit the O2·--dependent reduction of cytochrome c in this system, also inhibited Luc2+ luminescence. Thus it was apparent that the conditions leading to luminescence of Luc2+ and of LumH2 were fundamentally different in that the former required reduction and the latter oxidation. Superoxide dismutase was applied to probe for the involvement of O2·- in the luminescence of LumH2 elicited by several oxidants, including ferricyanide, persulfate, hypochlorite, and the XO/xanthine reactions.84 In all these cases, SOD was strongly inhibitory, implicating O2·-, and the mechanism proposed involved the univalent oxidation of LumH2 to a radical (LumH·), which could autoxidize with production of O2·-. The subsequent reaction of LumH· with O2·- would yield an unstable endoperoxide whose decomposition produced N2 plus aminophthallate in an excited state, which then emitted light during its return to the ground state. These results indicate that LumH2 luminescence is not a reliable indicator of O2·-, even when O2·- is a participant in the reactions leading to light emission, because LumH2 could mediate O2·- formation by a variety of oxidants. Moreover, there are O2·--independent routes to LumH2 luminescence such as that caused by HRP plus H2O2.85
The case with Luc2+ is somewhat analogous but different in that Luc2+ has to be univalently reduced to Luc+·, which can autoxidize with production of O2·-. Then, in a radical-radical addition reaction, Luc+· and O2·- combine, yielding an unstable dioxetane, whose decomposition produces two molecules of N-methyl acridone, one of which is in an excited state and emits light on return to the ground state. Lucigenin is very similar to paraquat in that both are dications that can be reduced to an autoxidizable monocation radical. Thus, Luc2+, like LumH2, can mediate O2·- production, with the difference that Luc2+ does so catalytically by a cycle of reduction followed by autoxidation, whereas LumH2 does so by two successive univalent oxidations, the first by hydroxyl radical, OCl-, ferricyanide, or another oxidant; and the second by O2.
Because of the frequent misuse of LumH2 and Luc2+ luminescence as supposedly specific detectors of O2·-, this chemistry has been previously reviewed.77 However, such is the triumph of hope over reality that the inappropriate use of these compounds continues. We then reported that Luc2+ could increase the production of O2·- in the XO/xanthine as well as the glucose oxidase plus glucose reactions,86,87 much as does paraquat, and in Escherichia coli, Luc2+ induced the soxRS regulon, again much as does paraquat.86 Others have also shown that Luc2+ mediates O2·- production by use of spin-trapping and other methods.88–90 The magnitude of overestimation of O2·- concentration appears related to the dose of Luc2+ used91 and has encouraged some to advocate use of a safe concentration of Luc2+. However, as Luc2+ undergoes redox-cycling to varying extents under different experimental conditions,91 the uncertainty concerning the precise mechanisms of enhanced Luc2+-dependent O2·- formation, particularly in a cell- or tissue-based experimental system, precludes knowledge of such a safe Luc2+ concentration. There are those whose faith in these luminescence methods remain unshaken; however, as is the case with NBT reduction, chemiluminescent techniques using Luc2+ or LumH2 will result in apparent rates of O2·- production that do not reflect actual cellular oxidant production.
In an effort to make use of the advantages of chemiluminescent techniques, other nonredox-cycling compounds have been studied for their utility as probes for O2·-. Coelenterazine is a lipophilic luminophore originally isolated from the coelenterate Aequorea and is the light-producing chromophore in the aequorin complex.79,92–94 Studies of the chemical nature of the excited species responsible for the luminescence of coelenterazine and related pyrazin-3-one compounds are incomplete but suggest that O2·--stimulated chemiluminescence occurs after direct oxidation to the acetamidopyrazine anion, which can then also be protonated to form additional neutral light-emitting excited species.94,95 Although the intensity of light emitted from the interaction of coelenterazine with O2·- is greater than Luc2+-dependent chemiluminescence, coelenterazine-dependent chemiluminescence is not entirely specific for O2·-, because ONOO- will also result in luminescence in the presence of coelenterazine.96 Selective use of NOS inhibitors as well as ONOO- scavengers may aid in discriminating between the contributions of O2·- and ONOO- to chemiluminescence under these circumstances.
Aconitase Inhibition
Aconitase, present in both the cytosol and mitochondria, catalyzes the interconversion of citrate to isocitrate. Aconitase is inactivated by O2·- because of oxidation followed by reversible loss of Fe from its cubane [4Fe-4S] cluster, with a rate constant of 106 to 107 [mol/L]-1·s-1.97–99 Because of basal endogenous production of O2·-, a small proportion of aconitase at any moment is inactive but capable of reactivation; this ratio of inactive/active aconitase increases as rates of O2·- production are augmented.100 Aconitase activity is determined by the relative rates of inactivation by O2·- or other oxidants and the rate of reactivation by reduction and restoration of iron to the cluster. Alterations in aconitase activity have been used as a sensitive index of changes in steady-state levels of O2·-.100–102 Using this method, steady-state O2·- concentrations have been estimated at 8 to 30 pmol/L in A549 lung epithelial cells under normal conditions (86% active aconitase) and 50 to 200 pmol/L in cells when 50% of aconitase is in the inactive form.101
Aconitase activity is measured in cell or tissue homogenates by monitoring spectrophotometrically the conversion of isocitrate to cis-aconitate at A240nm. Background interference may be avoided with a coupled assay where citrate serves as the aconitase substrate and the isocitrate formed is converted to -ketoglutarate by NADP+-dependent isocitrate dehydrogenase, permitting monitoring of NADPH formation at A340nm. Reactivation of aconitase activity is accomplished by addition of the reducing agent dithiothreitol, ferrous ammonium sulfate, and Na2S to cellular extracts and remeasuring aconitase activity.102
Other oxidants can modulate aconitase activity, in addition to O2·-. Peroxynitrite will oxidize the [4Fe-4S] cluster of the enzyme with subsequent loss of activity, which is restored by the addition of thiol reagents and reduced iron.98,99 The rate constant of this bimolecular reaction has been estimated at 105 [mol/L]-1·s-1.99 It has also been reported that NO itself can inhibit aconitase activity, but it is unclear if, in vivo, NO is directly responsible for significant enzyme inactivation or it is the result of ensuing ONOO- formation. The effect of NOS inhibition on extents of aconitase inactivation may help to determine the role of O2·- and NO-derived species in enzyme inactivation. Oxygen and H2O2 have also been noted to inhibit aconitase activity, albeit with rate constants 4 to 5 orders of magnitude lower than those noted for O2·- or ONOO-.97 Thus, a direct contribution of oxygen and H2O2 to oxidant-mediated aconitase inactivation is minimal.
Hydrogen Peroxide Production
Because of the rapid dismutation of O2·- to H2O2 (spontaneous, 105 [mol/L]-1 · s-1; SOD-catalyzed, 109 [mol/L]-1·s-1), endogenous rates of cellular H2O2 production can be used as an indirect measure of O2·- formation, recognizing that such measurements will also reflect direct divalent reduction of molecular oxygen to H2O2. Intracellular steady-state H2O2 can be estimated by aminotriazole-mediated catalase inactivation.103 A significant portion of cellularly derived H2O2 can also traverse the cell membrane and thus be measured in the extracellular space by HRP-catalyzed oxidation of homovanillic acid or p-hydroxyphenylacetic acid (see below). Use of a scavenger such as uric acid will control for ONOO--dependent oxidation of phenolic fluorophores.
Protection by SOD or LMW Scavengers of Reactive Species
A role for enhanced production of O2·- can be inferred when the addition of SOD or LMW SOD mimetics alters the effect seen in the absence of the antioxidant.5,104,105 Robust conclusions, however, can only be drawn when scavengers are used appropriately. For example, the lack of an effect of native CuZn SOD does not imply that O2·- is not involved in a given process if O2·- is formed at a site to which CuZn SOD is unable to gain access either because of size or charge considerations. Additionally, many SOD mimetics can also catalyze peroxidase and peroxynitrite isomerase reactions and thus may not be entirely specific for O2·-.106–108 Another approach is to use methods such as transgenic animals or transient transfection to study the effects of overexpression of SOD,109–111 a strategy complicated by frequent compensatory responses of cell antioxidant defense mechanisms.
Enhancement of Effect by Inhibition of SOD
In a similar manner, enhanced O2·- formation has been implicated when diminished SOD activity results in an alteration in response variables. Decreases in SOD activity can be attributable to chromosomal abnormalities,112 the addition of inhibitors such as metal chelators,4 or the use of transgenic animals113–115 and again may be complicated by nonspecific effects of inhibitors on other metalloproteins or compensatory tissue responses.
Hydrogen Peroxide Detection
Horse Radish Peroxidase–Linked Assays
Several assays for the detection of H2O2 depend on the oxidation of a detector compound. In the presence of H2O2, hydrogen donors are oxidized by HRP49:
|
|
|
|
The amount of H2O2 present is estimated by following the decrease in fluorescence of initially fluorescent probes, such as scopoletin (7-hydroxy-6-methoxy-coumarin),116 or by monitoring the increase in fluorescent products from previously nonfluorescent hydrogen donors, such as diacetyldichlorofluorescin,117 p-hydroxyphenylacetate,118 homovanillic acid (3-methoxy-4-hydroxyphenylacetic acid),119 or N-acetyl-3,7-dihydroxyphenoxazine.120 Spectrophotometric assays using the same principle include oxidation of tetramethylbenzidine121 or phenol red.122 Several caveats are necessary to reasonably use and interpret reporter molecule test systems when detecting H2O2 production in biological systems.
First, numerous biological substances, including thiol compounds and vitamin C, can serve as substrates for HRP and thus compete with the detector molecule for oxidation, leading to underestimation of H2O2 formation.
Second, competition with HRP by endogenous catalase for H2O2 can also lead to underestimation of H2O2. For example, in the scopoletin-HRP–coupled assay, rates of H2O2 formation in isolated mitochondria or submitochondrial particles ranged from 2% to 76% of those detected by either oxygen consumption or by H2O2-induced cytochrome c peroxidase Compound I formation.116
Third, quenching of fluorescent signals by cell and tissue components can lead to overestimation of H2O2 in the case of scopoletin or underestimation, as with homovanillic acid. When measuring cellular or subcellular H2O2 accumulation, accuracy of the assay can be improved by separation of the incubation media from cellular components before addition of the detection system, thus limiting confounding interactions of the detection system with cellular elements.121
Use of HRP-coupled reactions with spectrophotometric detection can also have limitations. Direct reduction of the oxidized detector molecule by electron transport components can limit the utility of tetramethylbenzidine in H2O2 determination, eg, in mitochondria.121 Although spectrophotometric detection of H2O2 with phenol red has been used successfully in purified enzyme–substrate mixtures and to detect H2O2 release from activated leukocytes,122 the phenol red–HRP assay is pH-dependent and less sensitive than fluorescent methods, reducing its utility when attempting to detect H2O2 from vascular tissue.
Catalase-Based Assays
The intermediate complex that is formed in catalase-dependent metabolism of H2O2 is stable; thus, steady-state monitoring of a H2O2-catalase complex (Compound I) can be followed with dual-wavelength spectrophotometry at 660 to 640 nm. The fraction of catalase heme present as Compound I depends not only on the rate of H2O2 formation but is influenced by the total catalase heme concentration and on the concentration of a hydrogen donor.123
|
Additional assays for H2O2 detection are based on the ability of catalase to act as a peroxidase. In the presence of H2O2, catalase will oxidize 14C-methanol to 14C-formaldehyde. To enhance the efficiency of the peroxidase reaction and to diminish competition from endogenous hydrogen donors, high concentrations of the hydrogen donor should be used relative to expected H2O2 levels. The potential for side reactions to occur with either substrate, eg, alcohol dehydrogenase, or product, eg, aldehyde dehydrogenase, must also be considered.123
Intracellular production of H2O2 can be estimated by using the catalase inhibitor, aminotriazole, which reacts with the Compound I intermediate; thus, catalase is inhibited by aminotriazole only in the presence of H2O2.124 By determining the half time of inactivation of catalase, steady-state H2O2 concentration can be approximated according to the following equation103,125:
|
|
|
|
Under conditions where glutathione peroxidase-reductase significantly contributes to metabolism of H2O2, calculations of H2O2 concentrations by this method will be underestimated.125
Ferrithiocyanate
Hydrogen peroxide oxidizes ferrous iron to the ferric state. Addition of thiocyanate to the ferric ions results in formation of a red complex with a peak in the 450 to 480 nm range.126 This method has been used to estimate H2O2 formation in hepatic microsomes,127 fibroblasts,128 and endothelial cells96 when fluorescent quenching and interference by tissue chromophores prevented use of alternative approaches.
Dichlorofluorescein Fluorescence
The oxidation of 2'-7'-dichlorofluorescin (DCFH) to the fluorescent compound 2'-7'-dichlorofluorescein (DCF) was initially thought to be a relatively specific indicator of H2O2 formation129 and has been used extensively in the detection of oxidants produced during the respiratory burst in inflammatory cells, either in cell lysates or in intact cells using flow cytometry.130,131 The diacetate form of DCFH (DCFH-DA) is taken up by cells, where intracellular esterases cleave the molecule to DCFH, which has been suggested to remain trapped intracellularly. In the presence of H2O2, DCFH is oxidized to DCF; fluorescence is measured with excitation at 498 nm and emission at 522. However, there are limitations to the interpretation of DCF fluorescence as a specific marker for quantitative intracellular H2O2 formation.
First, the H2O2-dependent oxidation of DCFH to DCF occurs slowly, if at all, in the absence of ferrous iron.132 DCF formation is greatly enhanced in the presence of heme-containing substances, such as hematin, peroxidases, or cytochrome c.132–135 Importantly, peroxidases are capable of inducing DCFH oxidation in the absence of H2O2.134,136,137 Thus, alterations in cellular peroxidase activity are likely to be equally if not more important than H2O2 in determining rates of DCF formation and cellular fluorescence.
Second, intracellularly formed DCFH does not necessarily remain within the confines of the intracellular space but rather can reaccumulate in extracellular media, where it would be available for reaction with extracellular oxidants.138
Third, the peroxidase-dependent formation of DCF from DCFH, both in the presence and absence of H2O2, is complex and generates both the DCF semiquinone free radical DCF·-136 and the DCF phenoxyl radical DCF·139 as well as O2·-. The dismutation of O2·- to H2O2 would then yield artifactual DCFH oxidation and amplification of DCF fluorescence.
In addition to peroxidase-dependent oxidation of DCFH, other substances are capable of directly inducing DCF formation in the absence of H2O2, including ONOO- and HOCl.140,141 In the presence of heme-containing compounds, lipid peroxides are also capable of generating DCF fluorescence.133
Because of the multiple pathways that can lead to DCF fluorescence and the inherent uncertainty relating to endogenous versus artifactual oxidant generation, this assay may best be applied as a qualitative marker of cellular oxidant stress rather than a precise indicator of rates of H2O2 formation.
Peroxynitrite Detection
Dihydrorhodamine Oxidation
Dihydrorhodamine 123 (DHR) is a cell-permeant, mitochondrial-avid analog of 2,7 dichlorodihydrofluorescein that can undergo oxidation to the fluorophore rhodamine 123. The oxidized rhodamine tends to be retained within the cell after tautomerization of its equivalent amino groups.138 Peroxynitrite readily oxidizes DHR 123; however, several cell-derived oxidants are also capable of oxidizing DHR 123. In addition to ONOO-, HOCl will also directly oxidize DHR 123.140 The direct reaction of DHR 123 with H2O2 does not occur but can be catalyzed by heme-containing peroxidases, such as HRP,134 or other heme compounds, including cytochrome c.138 Selective application of SOD, catalase, various NOS inhibitors, and ONOO- scavengers are required to provide for more precise identification of the substances responsible for DHR oxidation; thus, cellular oxidation of DHR 123 to rhodamine is at best a qualitative probe for ONOO-.
Chemiluminescent Reactions
Peroxynitrite reacts with LumH2 to yield chemiluminescence, a reaction enhanced by CO2 present in bicarbonate-containing systems attributable to formation of nitrosoperoxocarbonate (ONOOCO2-).142,143 Whereas O2·- does not directly react with LumH2,77 SOD inhibits ONOO--dependent LumH2 chemiluminescence. The mechanisms for SOD inhibition of ONOO--dependent LumH2 chemiluminescence include inhibition of ONOO- formation, SOD-dependent catalysis of ONOO- decomposition, and inhibition of O2·--mediated oxidation of preformed LumH2 radical.142,144 Excess NO can cause inhibition of ONOO--dependent LumH2 chemiluminescence via reaction with LumH2 radicals.144 Although not well described, ONOO- also rapidly reacts with another chemiluminescent probe used for detection of O2·-, coelenterazine.96 One potential strategy to thus discriminate between chemiluminescence that is principally derived from O2·- or ONOO- would be to also determine Luc2+ chemiluminescence under identical conditions, because ONOO- does not result in Luc2+-dependent chemiluminescence.144
Nitrotyrosine Formation
Formation of free and protein 3-nitrotyrosine (NO2Tyr) derivatives has been used as a probe for reactive nitrogen species (RNS)-mediated vascular injury in recent years.145 Tissue NO2Tyr may simply serve as a dosimeter to indicate extents of RNS reaction or may be present in proteins at levels that will impair protein, cell, and organ function. Nitration of protein tyrosine residues can readily alter function, because incorporation of a bulky NO2 group into tyrosine lowers the pKa of the phenolic group and imposes both steric and electronic perturbations that affect the capacity of tyrosine to function in electron-transfer reactions and maintenance of protein conformation.146–148 Although NO2Tyr is formed in diverse inflammatory diseases, only a few specific proteins have been identified as in vivo targets of NO-dependent posttranslational modification.149–152 A causal relationship between tyrosine nitration and disease pathology, although conceivable from encouraging in vitro observations, has not been unambiguously established. The detection of NO2Tyr in specific plasma proteins of ARDS patients, occurring in concert with changes in antiprotease and clotting protein function, is a promising advance in this regard.149 It is important to note that reactions of proteins with RNS, although yielding NO2Tyr, can also concurrently induce dityrosine formation and oxidative modification of even more RNS-susceptible protein targets (eg, cysteine, FeS, or ZnS complexes) that may actually be the proximal cause of impaired protein function.99,153,154 Thus, tyrosine nitration may parallel but not induce enzyme/protein dysfunction. A causal role for NO2Tyr as a mediator of inflammatory tissue injury must be reinforced by evidence that a specific tyrosine modification is critical for protein function and that other oxidative, nitrosative, or nitrative amino acid modifications are not responsible.
Because NO2Tyr formation in tissue inflammatory reactions represents a small fraction of total protein tyrosines (typically 0.01% to 0.10%), a contribution of NO2Tyr to impaired vascular cell protein function at first glance may be unlikely. However, if NO2Tyr formation preferentially occurs at specific amino acid motifs155 or at critical catalytic99 and structural residues153 of a few highly susceptible proteins, then low yields of NO2Tyr do not exclude NO2Tyr as a mediator of altered tissue structure and function. It is interesting to note that the yields of NO2Tyr in inflammatory events are similar in magnitude to the extents of tyrosine phosphorylation during cell signaling. It may also be plausible that tyrosine nitration can, in some cases, mimic tyrosine phosphorylation or adenylation as a novel mechanism for modulating protein function during inflammation.156 The identification of a NO2Tyr denitrase activity,157 conceptually similar to the protein phosphatases of tyrosine kinase signaling events, infers the reversibility of tyrosine nitration and supports nitration as a potential signaling event.
The principal mechanisms underlying tyrosine nitration in vascular diseases are subjects of ongoing investigation. Peroxynitrite will directly nitrate tyrosine in low yields, with transition metals catalyzing additional increases in yield.158 Peroxynitrite also reacts rapidly with adventitious CO2 to yield ONOOCO2-, with the radical products produced during decomposition of this intermediate viewed to be responsible for most ONOO--mediated nitration reactions.159 Peroxynitrite is commonly and often erroneously implicated as the principal mediator of tyrosine nitration. Other facile tyrosine nitration pathways can also be operative during inflammatory oxidative reactions; myeloperoxidase (MPO) and other metalloproteins capable of peroxidase activity can catalyze tyrosine nitration in the vascular compartment. For example, neutrophil-derived MPO is intimately linked with inflammatory events, concentrates in the subendothelial matrix after neutrophil degranulation, and frequently displays spatial and temporal colocalization with tyrosine nitration. Because substrates supporting peroxidase-dependent tyrosine nitration (NO, NO2-, and hydroperoxides) become abundantly available for MPO-dependent nitration reactions, it is likely that multiple mechanisms will account for tissue NO2Tyr formation in diverse vascular inflammatory events.154,160 The aforementioned ONOO-- and peroxidase-mediated nitration reactions all yield and occur via a common final and proximal nitrating species, NO2. Interestingly, acidification of NO2- will also result in a chemistry that can result in tyrosine nitration.161 It remains to be demonstrated, however, whether acidification of intracellular microenvironments occurs to an extent that leads to nitrative chemistry.
It is important to note that many acidic and peroxide-containing tissue preparations and analytical reaction conditions are used in the mass spectroscopic and immunohistochemical quantitation of tissue NO2Tyr formation. It has recently been convincingly demonstrated that these pitfalls can result in the artifactual generation of NO2Tyr and overestimation of tissue NO2Tyr content.162,163 Despite the present uncertainty as to proximal mediators of tyrosine nitration and the extent to which this occurs (eg, NO2Tyr/1000 tyr content of a protein or tissue preparation), the widespread occurrence and diverse mechanisms leading to tyrosine nitration underscore the significance of this process in inflammation.
In the future, it will be revealing to quantify in concert the multiple NO-dependent modifications that occur in vascular inflammatory reactions (nitrosative, nitrative, and oxidative chemistry), thus even more comprehensively reflecting the biochemical and oxidative nature of the inflammatory milieu. For now, the use of NO2Tyr as a marker of RNS-mediated vascular injury in clinical samples can yield insight into candidate mechanisms underlying oxidative tissue injury and provides a marker for pharmacological modulation at early points in vascular inflammatory responses.
|
Summary and Recommendations |
|---|
|
TopAbstractIntroductionNitric Oxide DetectionSummary and RecommendationsReferences |
|---|
From the above discussion, it is apparent that no single technique will accurately reflect quantitative rates of formation of a particular reactive species under all circumstances; ie, when measuring free radical and oxidizing species in vascular cells and tissues, one size will not fit all. Because of the often-overlapping capacity of reactive oxygen and nitrogen species to chemically react with detector molecules, robust conclusions concerning rates of formation of reactive species will be markedly enhanced when a multifaceted approach is used. With the provided mechanisms of reaction for reactive species and the detector molecules used in a particular assay system and the recognition and accounting for potentially significant side reactions, experimentalists should be able to more reliably use detection methods yielding data that accurately reflect cell and tissue conditions.
|
Acknowledgments |
|---|
This study was supported by grants from the National Institutes of Health (K08 HL-03457 and R01 HL-66110).
Received March 13, 2001; accepted June 12, 2001.
|
References |
|---|
|
TopAbstractIntroductionNitric Oxide DetectionSummary and RecommendationsReferences |
|---|
1. Rubanyi GM, Vanhoutte PM. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol. . 1986; 250: H822–H827.
2.
Omar HA, Cherry PD, Mortelliti MP, Burke-Wolin TM, Wolin MS. Inhibition of coronary artery superoxide dismutase attenuates endothelium-dependent and -independent nitrovasodilator relaxation. Circ Res. . 1991; 69: 601–608.
3.
Abrahamsson T, Brandt U, Marklund SL, Sjoqvist PO. Vascular bound recombinant extracellular superoxide dismutase type C protects against the detrimental effects of superoxide radicals on endothelium-dependent arterial relaxation. Circ Res. . 1992; 70: 264–271.
4.
Lynch SM, Frei B, Morrow JD, Roberts LJ, Xu A, Jackson T, Reyna R, Klevay LM, Vita JA, Keaney JF Jr. Vascular superoxide dismutase deficiency impairs endothelial vasodilator function through direct inactivation of nitric oxide and increased lipid peroxidation. Arterioscler Thromb Vasc Biol. . 1997; 17: 2975–2981.
5.
White CR, Brock TA, Chang LY, Crapo JD, Briscoe P, Ku DD, Bradley WA, Gianturco SH, Gore J, Freeman BA, Tarpey MM. Superoxide and peroxynitrite in atherosclerosis. Proc Natl Acad Sci USA. . 1994; 91: 1044–1048.
6.
Nakazono K, Watanabe N, Matsuno K, Sasaki J, Sato T, Inoue M. Does superoxide underlie the pathogenesis of hypertension? Proc Natl Acad Sci USA. . 1991; 88: 10045–10048.
7. Mullarkey CJ, Edelstein D, Brownlee M. Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochem Biophys Res Commun. . 1990; 173: 932–939.[Medline] [Order article via Infotrieve]
8.
Oskarsson HJ, Hofmeyer TG. Diabetic human platelets release a substance that inhibits platelet-mediated vasodilation. Am J Physiol. . 1997; 273: H371–H379.
9. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG. Angiotensin II -mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone. J Clin Invest. . 1996; 97: 1916–1923.[Medline] [Order article via Infotrieve]
10. Munzel T, Sayegh H, Freeman BA, Tarpey MM, Harrison DG. Evidence for enhanced vascular superoxide anion production in nitrate tolerance: a novel mechanism underlying tolerance and cross-tolerance. J Clin Invest. . 1995; 95: 187–194.
11.
Zweier JL. Measurement of superoxide-derived free radicals in the reperfused heart: evidence for a free radical mechanism of reperfusion injury. J Biol Chem. . 1988; 263: 1353–1357.
12.
Tsao PS, Buitrago R, Chan JR, Cooke JP. Fluid flow inhibits endothelial adhesiveness: nitric oxide and transcriptional regulation of VCAM-1. Circulation. . 1996; 94: 1682–1689.
13.
Marumo T, Schini-Kerth VB, Fisslthaler B, Busse R. Platelet-derived growth factor-stimulated superoxide anion production modulates activation of transcription factor NF-
B and expression of monocyte chemoattractant protein-1 in human aortic smooth muscle cells. Circulation. . 1997; 96: 2361–2367.
14.
Ushio-Fukai M, Alexander RW, Akers M, Yin Q, Fujio Y, Walsh K, Griendling KK. Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells. J Biol Chem. . 1999; 274: 22699–22704.
15. Patel RP, McAndrew J, Sellak H, White CR, Jo H, Freeman BA, Darley-Usmar VM. Biological aspects of reactive nitrogen species. Biochim Biophys Acta. . 1999; 1411: 385–400.[Medline] [Order article via Infotrieve]
16.
Wang P, Zweier JL. Measurement of nitric oxide and peroxynitrite generation in the postischemic heart: evidence for peroxynitrite-mediated reperfusion injury. J Biol Chem. . 1996; 271: 29223–29230.
17.
Go YM, Patel RP, Maland MC, Park H, Beckman JS, Darley-Usmar VM, Jo H. Evidence for peroxynitrite as a signaling molecule in flow-dependent activation of c-JunNH2-terminal kinase. Am J Physiol. . 1999; 277: H1647–H1653.
18. Brawn K, Fridovich I. Superoxide radical and superoxide dismutases: threat and defense. Acta Physiol Scand. . 1980; 492: 9–18.
19.
Lynch RE, Fridovich I. Permeation of the erythrocyte stroma by superoxide radical. J Biol Chem. . 1978; 253: 4697–4699.
20.
Rosen GM, Freeman BA. Detection of superoxide generated by endothelial cells. Proc Natl Acad Sci USA. . 1984; 81: 7269–7273.
21. Extracellular-superoxide dismutase, distribution in the body and therapeutic applications. Adv Exp Med Biol. . 1990; 264: 1–4.[Medline] [Order article via Infotrieve]
22. Skulachev VP. Membrane-linked systems preventing superoxide formation. Biosci Rep. . 1997; 17: 347–366.[Medline] [Order article via Infotrieve]
23. Halliwell B. How to characterize an antioxidant: an update. Biochem Soc Symp. . 1995; 61: 73–101.[Medline] [Order article via Infotrieve]
24. Rice-Evans CA, Diplock AT. Current status of antioxidant therapy. Free Radic Biol Med. . 1993; 15: 77–96.[Medline] [Order article via Infotrieve]
25. Tsukahara H, Gordienko DV, Goligorsky MS. Continuous monitoring of nitric oxide release from human umbilical vein endothelial cells. Biochem Biophys Res Commun. . 1993; 193: 722–729.[Medline] [Order article via Infotrieve]
26.
Engelman DT, Watanabe M, Engelman RM, Rousou JA, Flack JE, Deaton DW, Das DK. Constitutive nitric oxide release is impaired after ischemia and reperfusion. J Thorac Cardiovasc Surg. . 1995; 110: 1047–1053.
27. Vallance P, Patton S, Bhagat K, MacAllister R, Radomski M, Moncada S, Malinski T. Direct measurement of nitric oxide in human beings. Lancet. . 1995; 346: 153–154.[Medline] [Order article via Infotrieve]
28. Gerhardt GA, Oke AF, Nagy G, Moghaddam B, Adams RN. Nafion-coated electrodes with high selectivity for CNS electrochemistry. Brain Res. . 1984; 290: 390–395.[Medline] [Order article via Infotrieve]
29. Christodoulou D, Kudo S, Cook JA, Krishna MC, Miles A, Grisham MB, Murugesan M, Ford PC, Wink DA. Electrochemical methods for detection of nitric oxide. Methods Enzymol. . 1996; 268: 69–83.[Medline] [Order article via Infotrieve]
30. Doyle MP, Hoekstra JW. Oxidation of nitrogen oxides by bound dioxygen in hemoproteins. J Inorg Biochem. . 1981; 14: 351–358.[Medline] [Order article via Infotrieve]
31. Sutton HC, Roberts PB, Winterbourn CC. The rate of reaction of superoxide radical ion with oxyhaemoglobin and methaemoglobin. Biochem J. . 1976; 155: 503–510.[Medline] [Order article via Infotrieve]
32.
Kelm M, Dahmann R, Wink D, Feelisch M. The nitric oxide/superoxide: insights into the biological chemistry of the NO/O2 interaction. J Biol Chem. . 1997; 272: 9922–9932.
33. Braman RS, Hendrix SA. Nanogram nitrite and nitrate determination in environmental and biological materials by vanadium (III) reduction with chemiluminescence detection. Anal Chem. . 1989; 61: 2715–2718.[Medline] [Order article via Infotrieve]
34. Medina A, Nicholas DJD. Interference by reduced pyridine nucleotides in the diazotization of nitrite. Biochim Biophys Acta. . 1957; 23: 440–442.[Medline] [Order article via Infotrieve]
35.
Bredt DS, Snyder SH. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci USA. . 1989; 86: 9030–9033.
36. Bredt DS, Schmidt HH. The citrulline assay. In: Feelisch M, Stamler JS, eds. Methods in Nitric Oxide Research. Chichester, UK: Wiley; 1996: 249–255.
37.
Iyengar R, Stuehr DJ, Marletta MA. Macrophage synthesis of nitrite, nitrate, and N-nitrosamines: precursors and role of the respiratory burst. Proc Natl Acad Sci USA. . 1987; 84: 6369–6373.
38. Hecker M, Billiar TR. Detection of L-arginine, related metabolites and guanidino compounds. In: Feelisch M, Stamler JS, eds. Methods in Nitric Oxide Research. Chichester, UK: Wiley; 1996: 259–170.
39.
Hecker M, Sessa WC, Harris HJ, Anggard EE, Vane JR. The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: cultured endothelial cells recycle L-citrulline to L-arginine. Proc Natl Acad Sci USA. . 1990; 87: 8612–8616.
40. Land EJ, Swallow AJ. One-electron reactions in biochemical systems as studied by pulse radiolysis, V: cytochrome c. Arch Biochem Biophys. . 1971; 145: 365–372.[Medline] [Order article via Infotrieve]
41. Ballou D, Palmer G, Massey V. Direct demonstration of superoxide anion production during the oxidation of reduced flavin and of its catalytic decomposition by erythrocuprein. Biochem Biophys Res Commun. . 1969; 36: 898–904.[Medline] [Order article via Infotrieve]
42. Massey V. The microestimation of succinate and the extinction coefficient of cytochrome c. Biochim Biophys Acta. . 1959; 34: 255–256.[Medline] [Order article via Infotrieve]
43. Fridovich I. Cytochrome c. In: Greenwald RA, ed. Handbook of Methods for Oxygen Radical Research. Boca Raton, Fla: CRC Press; 1985: 121–122.
44. Thomson L, Trujillo M, Telleri R, Radi R. Kinetics of cytochrome c2+ oxidation by peroxynitrite: implications for superoxide measurements in nitric oxide-producing biological systems. Arch Biochem Biophys. . 1995; 319: 491–497.[Medline] [Order article via Infotrieve]
45. O’Brien PJ. Superoxide production. Methods Enzymol. . 1984; 105: 370–378.[Medline] [Order article via Infotrieve]
46. Azzi A, Montecucco C, Richter C. The use of acetylated ferricytochrome c for the detection of superoxide radicals produced in biological membranes. Biochem Biophys Res Commun. . 1975; 65: 597–603.[Medline] [Order article via Infotrieve]
47. Kuthan H, Ullrich V, Estabrook RW. A quantitative test for superoxide radicals produced in biological systems. Biochem J. . 1982; 203: 551–558.[Medline] [Order article via Infotrieve]
48. Auclair C, Voisin E. Nitroblue tetrazolium reduction. In: Greenwald RA, ed. CRC Handbook of Methods for Oxygen Radical Research. Boca Raton, Fla: CRC Press; 1985: 123–132.
49. Boveris A. Determination of the production of superoxide radicals and hydrogen peroxide in mitochondria. Methods Enzymol. . 1984; 105: 429–435.[Medline] [Order article via Infotrieve]
50.
Misra HP, Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem. . 1972; 247: 3170–3175.
51. Hassan HM, Fridovich I. Intracellular production of superoxide radical and of hydrogen peroxide by redox-active compounds. Arch Biochem Biophys. . 1979; 196: 385–395.[Medline] [Order article via Infotrieve]
52.
Freeman BA, Crapo JD. Hyperoxia increases oxygen radical production in rat lungs and lung mitochondria. J Biol Chem. . 1981; 256: 10986–10992.
53. Turrens JF, Freeman BA, Levitt JG, Crapo JD. The effect of hyperoxia on superoxide production by lung submitochondrial particles. Arch Biochem Biophys. . 1982; 217: 401–410.[Medline] [Order article via Infotrieve]
54. Benov L, Sztejnberg L, Fridovich I. Critical evaluation of the use of hydroethidine as a measure of superoxide anion radical. Free Radic Biol Med. . 1998; 25: 826–831.[Medline] [Order article via Infotrieve]
55. Carter WO, Narayanan PK, Robinson JP. Intracellular hydrogen peroxide and superoxide anion detection in endothelial cells. J Leukoc Biol. . 1994; 55: 253–258.[Abstract]
56.
Bindokas VP, Jordan J, Lee CC, Miller RJ. Superoxide production in rat hippocampal neurons: selective imaging with hydroethidine. J Neurosci. . 1996; 16: 1324–1336.
57.
Green DR, Reed JC. Mitochondria and apoptosis. Science. . 1998; 281: 1309–1312.
58. Cai J, Yang J, Jones DP. Mitochondrial control of apoptosis: the role of cytochrome c. Biochim Biophys Acta. . 1998; 1366: 139–149.[Medline] [Order article via Infotrieve]
59. Tanaka K, Kobayashi F, Isogai Y, Iizuka T. Electrochemical determination of superoxide anions generated from a single neutrophil. Bio- electrochem Bioenerg. . 1991; 26: 413–421.
60. Lvovich V, Scheeline A. Amperometric sensors for simultaneous superoxide and hydrogen peroxide detection. Anal Chem. . 1997; 69: 454–462.
61. Mesaros S, Vankova Z, Grunfeld S, Mesarosova A, Malinski T. Peparation and optimization of superoxide microbiosensor. Anal Chim Acta. . 1998; 358: 27–33.
62.
Borbat PP, Costa-Filho AJ, Earle KA, Moscicki JK, Freed JH. Electron spin resonance in studies of membranes and proteins. Science. . 2001; 291: 266–269.
63. Baker JE, Froncisz W, Joseph J, Kalyanaraman B. Spin label oximetry to assess extracellular oxygen during myocardial ischemia. Free Radic Biol Med. . 1997; 22: 109–115.[Medline] [Order article via Infotrieve]
64. Velan SS, Spencer RG, Zweier JL, Kuppusamy P. Electron paramagnetic resonance oxygen mapping (EPROM): direct visualization of oxygen concentration in tissue. Magn Reson Med. . 2000; 43: 804–809.[Medline] [Order article via Infotrieve]
65.
Laurindo FR, Pedro MD, Barbeiro HV, Pileggi F, Carvalho MH, Augusto O, da Luz PL. Vascular free radical release: ex vivo and in vivo evidence for a flow-dependent endothelial mechanism. Circ Res. . 1994; 74: 700–709.
66. Makino K, Hagiwara T, Hagi A, Nishi M, Murakami A. Cautionary note for DMPO spin trapping in the presence of iron ion. Biochem Biophys Res Commun. . 1990; 172: 1073–1080.[Medline] [Order article via Infotrieve]
67. Frejaville C, Karoui H, Tuccio B, Le Moigne F, Culcasi M, Pietri S, Lauricella R, Tordo P. 5-(Diethoxyphosphoryl)-5-methyl-1-pyrroline N-oxide: a new efficient phosphorylated nitrone for the in vitro and in vivo spin trapping of oxygen-centered radicals. J Med Chem. . 1995; 38: 258–265.[Medline] [Order article via Infotrieve]
68. Roubaud V, Sankarapandi S, Kuppusamy P, Tordo P, Zweier JL. Quantitative measurement of superoxide generation using the spin trap 5-(diethoxyphosphoryl)-5-methyl-1-pyrroline-N-oxide. Anal Biochem. . 1997; 247: 404–411.[Medline] [Order article via Infotrieve]
69.
Vasquez-Vivar J, Kalyanaraman B, Kennedy MC. Mitochondrial aconitase is a source of hydroxyl radical: an electron spin resonance investigation. J Biol Chem. . 2000; 275: 14064–14069.
70. Dambrova M, Baumane L, Kalvinsh I, Wikberg JE. Improved method for EPR detection of DEPMPO-superoxide radicals by liquid nitrogen freezing. Biochem Biophys Res Commun. . 2000; 275: 895–898.[Medline] [Order article via Infotrieve]
71. Henry Y, Lepoivre M, Drapier JC, Ducrocq C, Boucher JL, Guissani A. EPR characterization of molecular targets for NO in mammalian cells and organelles. FASEB J. . 1993; 7: 1124–1134.[Abstract]
72.
Lancaster JR Jr, Langrehr JM, Bergonia HA, Murase N, Simmons RL, Hoffman RA. EPR detection of heme and nonheme iron-containing protein nitrosylation by nitric oxide during rejection of rat heart allograft. J Biol Chem. . 1992; 267: 10994–10998.
73.
Glover RE, Ivy ED, Orringer EP, Maeda H, Mason RP. Detection of nitrosyl hemoglobin in venous blood in the treatment of sickle cell anemia with hydroxyurea. Mol Pharmacol. . 1999; 55: 1006–1010.
74. Kalyanaraman B. Detection of nitric oxide by electron spin resonance in chemical, photochemical, cellular, physiological, and pathophysiological systems. Methods Enzymol. . 1996; 268: 168–187.[Medline] [Order article via Infotrieve]
75. Quaresima V, Ferrari M. Current status of electron spin resonance (ESR) for in vivo detection of free radicals. Phys Med Biol. . 1998; 43: 1937–1947.[Medline] [Order article via Infotrieve]
76. Fujii H, Berliner LJ. Nitric oxide: prospects and perspectives of in vivo detection by L-band EPR spectroscopy. Phys Med Biol. . 1998; 43: 1949–1956.[Medline] [Order article via Infotrieve]
77. Faulkner K, Fridovich I. Luminol and lucigenin as detectors for O2-. Free Radic Biol Med. . 1993; 15: 447–451.[Medline] [Order article via Infotrieve]
78. Lucas M, Solano F. Coelenterazine is a superoxide anion-sensitive chemiluminescent probe: its usefulness in the assay of respiratory burst in neutrophils. Anal Biochem. . 1992; 206: 273–277.[Medline] [Order article via Infotrieve]
79. Nakano M. Determination of superoxide radical and singlet oxygen based on chemiluminescence of luciferin analogs. Methods Enzymol. . 1990; 186: 585–591.[Medline] [Order article via Infotrieve]
80. Gleu K, Petsch W. Die chemiluminescenz der dimethyldiacridyliumsalze. Angew Chem. . 1935; 48: 57–59.
81.
Totter JR, Medina VJ, Scoseria JL. Luminescence during the oxidation of hypoxanthine by xanthine oxidase in the presence of dimethylbiacridylium nitrate. J Biol Chem. . 1960; 235: 238–241.
82.
Totter JR, Castro de Dugros E, Riveiro C. The use of chemiluminescent compounds as possible indicators of radical production during xanthine oxidase action. J Biol Chem. . 1960; 235: 1839–1842.
83. Greenlee L, Fridovich I, Handler P. Chemiluminescence induced by the operation of iron flavoproteins. Biochemistry. . 1962; 1: 779–783.[Medline] [Order article via Infotrieve]
84. Hodgson EK, Fridovich I. The role of O2- in the chemiluminescence of luminol. Photochem Photobiol. . 1973; 18: 451–455.[Medline] [Order article via Infotrieve]
85. Wong JK, Salin ML. Quenching of peroxidized luminol chemiluminescence by reduced pyridine nucleotides. Photochem Photobiol. . 1981; 33: 737–740.
86.
Liochev SI, Fridovich I. Lucigenin luminescence as a measure of intracellular superoxide dismutase activity in Escherichia coli. Proc Natl Acad Sci USA. . 1997; 94: 2891–2896.
87. Liochev SI, Fridovich I. Lucigenin as mediator of superoxide production-revisited. Free Radic Biol Med. . 1998; 25: 926–928.[Medline] [Order article via Infotrieve]
88. Vasquez-Vivar J, Hogg N, Pritchard KA Jr, Martasek P, Kalyanaraman B. Superoxide anion formation from lucigenin: an electron spin resonance spin-trapping study. FEBS Lett. . 1997; 403: 127–130.[Medline] [Order article via Infotrieve]
89. Skatchkov MP, Sperling D, Hink U, Anggard E, Munzel T. Quantification of superoxide radical formation in intact vascular tissue using a cypridina luciferin analog as an alternative to lucigenin. Biochem Biophys Res Commun. . 1998; 248: 382–386.[Medline] [Order article via Infotrieve]
90. Tsukamoto M, Tampo Y, Yonaha M. Lucigenin reduction by NADPH-cytochrome P450 reductase and the effect of phospholipids and albumin on chemiluminescence. Biochem Mol Biol Int. . 1998; 45: 115–123.[Medline] [Order article via Infotrieve]
91.
Li Y, Zhu H, Kuppusamy P, Roubaud V, Zweier JL, Trush MA. Validation of lucigenin (bis-N-methylacridinium) as a chemilumigenic probe for detecting superoxide anion radical production by enzymatic and cellular systems. J Biol Chem. . 1998; 273: 2015–2023.
92.
Shimomura O, Johnson FH. Peroxidized coelenterazine, the active group in the photoprotein aequorin. Proc Natl Acad Sci USA. . 1978; 75: 2611–2615.
93. Nakano M. Assay for superoxide dismutase based on chemiluminescence of luciferin analog. Methods Enzymol. . 1990; 186: 227–232.[Medline] [Order article via Infotrieve]
94. Teranishi K, Shimomura O. Coelenterazine analogs as chemiluminescent probe for superoxide anion. Anal Biochem. . 1997; 249: 37–43.[Medline] [Order article via Infotrieve]
95. Goto T, Inoue S, Sugiura S, Nishikawa K, Isobe M, Abe Y. Cypridina bioluminescence, V: structure of emitting species in the luminescence of cypridina luciferin and its related compounds. Tetrahedron Lett. . 1968; 37: 4035–4038.[Medline] [Order article via Infotrieve]
96.
Tarpey MM, White CR, Suarez E, Richardson G, Radi R, Freeman BA. Chemiluminescent detection of oxidants in vascular tissue: lucigenin but not coelenterazine enhances superoxide formation. Circ Res. . 1999; 84: 1203–1211.
97.
Flint DH, Tuminello JF, Emptage MH. The inactivation of Fe-S cluster containing hydro-lyases by superoxide. J Biol Chem. . 1993; 268: 22369–22376.
98.
Hausladen A, Fridovich I. Superoxide and peroxynitrite inactivate aconitases, but nitric oxide does not. J Biol Chem. . 1994; 269: 29405–29408.
99.
Castro L, Rodriguez M, Radi R. Aconitase is readily inactivated by peroxynitrite, but not by its precursor, nitric oxide. J Biol Chem. . 1994; 269: 29409–29415.
100.
Gardner PR, Fridovich I. Inactivation-reactivation of aconitase in Escherichia coli: a sensitive measure of superoxide radical. J Biol Chem. . 1992; 267: 8757–8763.
101.
Gardner PR, Raineri I, Epstein LB, White CW. Superoxide radical and iron modulate aconitase activity in mammalian cells. J Biol Chem. . 1995; 270: 13399–13405.
102. Hausladen A, Fridovich I. Measuring nitric oxide and superoxide: rate constants for aconitase reactivity. Methods Enzymol. . 1996; 269: 37–41.[Medline] [Order article via Infotrieve]
103.
Royall JA, Gwin PD, Parks DA, Freeman BA. Responses of vascular endothelial oxidant metabolism to lipopolysaccharide and tumor necrosis factor-. Arch Biochem Biophys. . 1992; 294: 686–694.[Medline]
[Order article via Infotrieve]
104.
Mugge A, Elwell JH, Peterson TE, Hofmeyer TG, Heistad DD, Harrison DG. Chronic treatment with polyethylene-glycolated superoxide dismutase partially restores endothelium-dependent vascular relaxations in cholesterol-fed rabbits. Circ Res. . 1991; 69: 1293–1300.
105. Batinic-Haberle I, Liochev SI, Spasojevic I, Fridovich I. A potent superoxide dismutase mimic: manganese ß-octabromo-meso-tetrakis-(N-methylpyridinium-4-yl) porphyrin. Arch Biochem Biophys. . 1997; 343: 225–233.[Medline] [Order article via Infotrieve]
106. Day BJ, Fridovich I, Crapo JD. Manganic porphyrins possess catalase activity and protect endothelial cells against hydrogen peroxide-mediated injury. Arch Biochem Biophys. . 1997; 347: 256–262.[Medline] [Order article via Infotrieve]
107. Ferrer-Sueta G, Batinic-Haberle I, Spasojevic I, Fridovich I, Radi R. Catalytic scavenging of peroxynitrite by isomeric Mn(III)-N-methylpyridylporphyrins in the presence of reductants. Chem Res Toxicol. . 1999; 12: 442–449.[Medline] [Order article via Infotrieve]
108.
Misko TP, Highkin MK, Veenhuizen AW, Manning PT, Stern MK, Currie MG, Salvemini D. Characterization of the cytoprotective action of peroxynitrite decomposition catalysts. J Biol Chem. . 1998; 273: 15646–15653.
109. Kubisch HM, Wang J, Bray TM, Phillips JP. Targeted overexpression of Cu/Zn superoxide dismutase protects pancreatic ß-cells against oxidative stress. Diabetes. . 1997; 46: 1563–1566.[Abstract]
110.
Ho YS, Vincent R, Dey MS, Slot JW, Crapo JD. Transgenic models for the study of lung antioxidant defense: enhanced manganese-containing superoxide dismutase activity gives partial protection to B6C3 hybrid mice exposed to hyperoxia. Am J Respir Cell Mol Biol. . 1998; 18: 538–547.
111. Woo YJ, Zhang JC, Vijayasarathy C, Zwacka RM, Englehardt JF, Gardner TJ, Sweeney HL. Recombinant adenovirus-mediated cardiac gene transfer of superoxide dismutase and catalase attenuates postischemic contractile dysfunction. Circulation. . 1998; 98: II255–II260.
112. Ackerman AD, Fackler JC, Tuck-Muller CM, Tarpey MM, Freeman BA, Rogers MC. Partial monosomy 21, diminished activity of superoxide dismutase, and pulmonary oxygen toxicity. N Engl J Med. . 1988; 318: 1666–1669.[Medline] [Order article via Infotrieve]
113. Ho YS, Magnenat JL, Gargano M, Cao J. The nature of antioxidant defense mechanisms: a lesson from transgenic studies. Env Health Perspect. . 1998; 106 (suppl 5): 1219–1228.
114. Huang TT, Yasunami M, Carlson EJ, Gillespie AM, Reaume AG, Hoffman EK, Chan PH, Scott RW, Epstein CJ. Superoxide-mediated cytotoxicity in superoxide dismutase-deficient fetal fibroblasts. Arch Biochem Biophys. . 1997; 344: 424–432.[Medline] [Order article via Infotrieve]
115.
Carlsson LM, Jonsson J, Edlund T, Marklund SL. Mice lacking extracellular superoxide dismutase are more sensitive to hyperoxia. Proc Natl Acad Sci USA. . 1995; 92: 6264–6268.
116. Boveris A, Martino E, Stoppani AO. Evaluation of the horseradish peroxidase-scopoletin method for the measurement of hydrogen peroxide formation in biological systems. Anal Biochem. . 1977; 80: 145–158.[Medline] [Order article via Infotrieve]
117.
Hinkle PC, Butow RA, Racker E, Chance B. Partial resolution of the enzymes catalyzing oxidative phosphorylation, XV: reverse electron transfer in the flavin-cytochrome ß region of the respiratory chain of beef heart submitochondrial particles. J Biol Chem. . 1967; 242: 5169–5173.
118. Hyslop PA, Sklar LA. A quantitative fluorimetric assay for the determination of oxidant production by polymorphonuclear leukocytes: its use in the simultaneous fluorimetric assay of cellular activation processes. Anal Biochem. . 1984; 141: 280–286.[Medline] [Order article via Infotrieve]
119. Ruch W, Cooper PH, Baggiolini M. Assay of H2O2 production by macrophages and neutrophils with homovanillic acid and horse-radish peroxidase. J Immunol Methods. . 1983; 63: 347–357.[Medline] [Order article via Infotrieve]
120. Cohen G, Kim M, Ogwu V. A modified catalase assay suitable for a plate reader and for the analysis of brain cell cultures. J Neurosci Methods. . 1996; 67: 53–56.[Medline] [Order article via Infotrieve]
121. Staniek K, Nohl H. H2O2 detection from intact mitochondria as a measure for one-electron reduction of dioxygen requires a non-invasive assay system. Biochim Biophys Acta. . 1999; 1413: 70–80.[Medline] [Order article via Infotrieve]
122. Pick E, Keisari Y. A simple colorimetric method for the measurement of hydrogen peroxide produced by cells in culture. J Immunol Methods. . 1980; 38: 161–170.[Medline] [Order article via Infotrieve]
123. Sies H. Measurement of hydrogen peroxide formation in situ. Methods Enzymol. . 1981; 77: 15–20.[Medline] [Order article via Infotrieve]
124. Margoliash E, Novogrodsky A, Schejter A. Irreversible reaction of 3-amino-1: 2,4-triazole and related inhibitors with the protein catalase. Biochem J. . 1960; 74: 339–348.[Medline] [Order article via Infotrieve]
125. Kinnula VL, Mirza Z, Crapo JD, Whorton AR. Modulation of hydrogen peroxide release from vascular endothelial cells by oxygen. Am J Respir Cell Mol Biol. . 1993; 9: 603–609.
126. Melnick LM. Iron. In: Kolthoff IM, Elving PJ, Sandell EB, eds. Treatise on Analytical Chemistry, Part II: Analytical Chemistry of the Elements. Vol 2. New York, NY: Interscience Publishers; 1962: 247–310.
127. Thurman RG, Ley HG, Scholz R. Hepatic microsomal ethanol oxidation: hydrogen peroxide formation and the role of catalase. Eur J Biochem. . 1972; 25: 420–430.[Medline] [Order article via Infotrieve]
128.
Shi M, Gozal E, Choy HA, Forman HJ. Extracellular glutathione and 
-glutamyl-transpeptidase prevent H2O2-induced injury by 2,3-dimethoxy-1,4-naphthoquinone. Free Radic Biol Med. . 1993; 15: 57–67.[Medline]
[Order article via Infotrieve]
129. Keston AS, Brandt R. The fluorometric analysis of ultramicro quantities of hydrogen peroxide. Anal Biochem. . 1965; 11: 1–5.[Medline] [Order article via Infotrieve]
130. Paul B, Sbarra AJ. The role of the phagocyte in host-parasite interactions, 13: the direct quantitative estimation of H2O2 in phagocytizing cells. Biochim Biophys Acta. . 1968; 156: 168–178.[Medline] [Order article via Infotrieve]
131. Bass DA, Parce JW, Dechatelet LR, Szejda P, Seeds MC, Thomas M. Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J Immunol. . 1983; 130: 1910–1917.[Abstract]
132. Rothe G, Valet G. Flow cytometric analysis of respiratory burst activity in phagocytes with hydroethidine and 2`,7`-dichlorofluorescin. J Leukoc Biol. . 1990; 47: 440–448.[Abstract]
133. Cathcart R, Schwiers E, Ames BN. Detection of picomole levels of hydroperoxides using a fluorescent dichlorofluorescein assay. Anal Biochem. . 1983; 134: 111–116.[Medline] [Order article via Infotrieve]
134. LeBel CP, Ischiropoulos H, Bondy SC. Evaluation of the probe 2`,7`-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem Res Toxicol. . 1992; 5: 227–231.[Medline] [Order article via Infotrieve]
135. Huang X, Frenkel K, Klein CB, Costa M. Nickel induces increased oxidants in intact cultured mammalian cells as detected by dichlorofluorescein fluorescence. Toxicol Appl Pharmacol. . 1993; 120: 29–36.[Medline] [Order article via Infotrieve]
136. Rota C, Chignell CF, Mason RP. Evidence for free radical formation during the oxidation of 2`-7`-dichlorofluorescin to the fluorescent dye 2`-7`-dichlorofluorescein by horseradish peroxidase: possible implications for oxidative stress measurements. Free Radic Biol Med. . 1999; 27: 873–881.[Medline] [Order article via Infotrieve]
137. Larsen LN, Dahl E, Bremer J. Peroxidative oxidation of leuco-dichlorofluorescein by prostaglandin H synthase in prostaglandin biosynthesis from polyunsaturated fatty acids. Biochim Biophys Acta. . 1996; 1299: 47–53.[Medline] [Order article via Infotrieve]
138. Royall JA, Ischiropoulos H. Evaluation of 2`,7`-dichlorofluorescin and dihydrorhodamine 123 as fluorescent probes for intracellular H2O2 in cultured endothelial cells. Arch Biochem Biophys. . 1993; 302: 348–355.[Medline] [Order article via Infotrieve]
139.
Rota C, Fann YC, Mason RP. Phenoxyl free radical formation during the oxidation of the fluorescent dye 2`,7`-dichlorofluorescein by horseradish peroxidase: possible consequences for oxidative stress measurements. J Biol Chem. . 1999; 274: 28161–28168.
140. Crow JP. Dichlorodihydrofluorescein and dihydrorhodamine 123 are sensitive indicators of peroxynitrite in vitro: implications for intracellular measurement of reactive nitrogen and oxygen species. Nitric Oxide. . 1997; 1: 145–157.[Medline] [Order article via Infotrieve]
141. Kooy NW, Royall JA, Ischiropoulos H. Oxidation of 2`,7`-dichlorofluorescin by peroxynitrite. Free Radic Res. . 1997; 27: 245–254.[Medline] [Order article via Infotrieve]
142. Radi R, Cosgrove TP, Beckman JS, Freeman BA. Peroxynitrite-induced luminol chemiluminescence. Biochem J. . 1993; 290: 51–57.
143. Radi R, Denicola A, Freeman BA. Peroxynitrite reactions with carbon dioxide-bicarbonate. Methods Enzymol. . 1999; 301: 353–367.[Medline] [Order article via Infotrieve]
144. Castro L, Alvarez MN, Radi R. Modulatory role of nitric oxide on superoxide-dependent luminol chemiluminescence. Arch Biochem Biophys. . 1996; 333: 179–188.[Medline] [Order article via Infotrieve]
145. Ischiropoulos H. Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch Biochem Biophys. . 1998; 356: 1–11.[Medline] [Order article via Infotrieve]
146.
Cassina AM, Hodara R, Souza JM, Thomson L, Castro L, Ischiropoulos H, Freeman BA, Radi R. Cytochrome c nitration by peroxynitrite. J Biol Chem. . 2000; 275: 21409–21415.
147.
Eiserich JP, Estevez AG, Bamberg TV, Ye YZ, Chumley PH, Beckman JS, Freeman BA. Microtubule dysfunction by posttranslational nitrotyrosination of -tubulin: a nitric oxide-dependent mechanism of cellular injury. Proc Natl Acad Sci USA. . 1999; 96: 6365–6370.
148.
Zhu S, Basiouny KF, Crow JP, Matalon S. Carbon dioxide enhances nitration of surfactant protein A by activated alveolar macrophages. Am J Physiol. . 2000; 278: L1025–L1031.
149.
Gole MD, Souza JM, Choi I, Hertkorn C, Malcolm S, Foust RF III, Finkel B, Lanken PN, Ischiropoulos H. Plasma proteins modified by tyrosine nitration in acute respiratory distress syndrome. Am J Physiol. . 2000; 278: L961–L967.
150.
MacMillan-Crow LA, Crow JP, Kerby JD, Beckman JS, Thompson JA. Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. Proc Natl Acad Sci USA. . 1996; 93: 11853–11858.
151. Viner RI, Ferrington DA, Williams TD, Bigelow DJ, Schoneich C. Protein modification during biological aging: selective tyrosine nitration of the SERCA2a isoform of the sarcoplasmic reticulum Ca2+-ATPase in skeletal muscle. Biochem J. . 1999; 340: 657–669.
152.
Zhu S, Ware LB, Geiser T, Matthay MA, Matalon S. Increased levels of nitrate and surfactant protein A nitration in the pulmonary edema fluid of patients with acute lung injury. Am J Respir Crit Care Med. . 2001; 163: 166–172.
153.
Kuhn DM, Geddes TJ. Peroxynitrite inactivates tryptophan hydroxylase via sulfhydryl oxidation: coincident nitration of enzyme tyrosyl residues has minimal impact on catalytic activity. J Biol Chem. . 1999; 274: 29726–29732.
154.
Van der Vliet A, Eiserich JP, Shigenaga MK, Cross CE. Reactive nitrogen species and tyrosine nitration in the respiratory tract: epiphenomena or a pathobiologic mechanism of disease? Am J Respir Crit Care Med. . 1999; 160: 1–9.
155. Souza JM, Daikhin E, Yudkoff M, Raman CS, Ischiropoulos H. Factors determining the selectivity of protein tyrosine nitration. Arch Biochem Biophys. . 1999; 371: 169–178.[Medline] [Order article via Infotrieve]
156.
Berlett BS, Levine RL, Stadtman ER. Carbon dioxide stimulates peroxynitrite-mediated nitration of tyrosine residues and inhibits oxidation of methionine residues of glutamine synthetase: both modifications mimic effects of adenylylation. Proc Natl Acad Sci USA. . 1998; 95: 2784–2789.
157.
Kamisaki Y, Wada K, Bian K, Balabanli B, Davis K, Martin E, Behbod F, Lee YC, Murad F. An activity in rat tissues that modifies nitrotyrosine-containing proteins. Proc Natl Acad Sci USA. . 1998; 95: 11584–11589.
158.
Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol. . 1996; 271: C1424–C1437.
159.
Tien M, Berlett BS, Levine RL, Chock PB, Stadtman ER. Peroxynitrite-mediated modification of proteins at physiological carbon dioxide concentration: pH dependence of carbonyl formation, tyrosine nitration, and methionine oxidation. Proc Natl Acad Sci USA. . 1999; 96: 7809–7814.
160. Eiserich JP, Hristova M, Cross CE, Jones AD, Freeman BA, Halliwell B, Van der Vliet A. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature. . 1998; 391: 393–397.[Medline] [Order article via Infotrieve]
161. Knowles ME, McWeeny DJ, Couchman L, Thorogood M. Interaction of nitrite with proteins at gastric pH. Nature. . 1974; 247: 288–289.[Medline] [Order article via Infotrieve]
162. Yi D, Ingelse BA, Duncan MW, Smythe GA. Quantification of 3-nitrotyrosine in biological tissues and fluids: generating valid results by eliminating artifactual formation. J Am Soc Mass Spectrom. . 2000; 11: 578–586.[Medline] [Order article via Infotrieve]
163. Frost MT, Halliwell B, Moore KP. Analysis of free and protein-bound nitrotyrosine in human plasma by a gas chromatography/mass spectrometry method that avoids nitration artifacts. Biochem J. . 2000; 345: 453–458.
This article has been cited by other articles:
 |
|
 |
|
  G. J. Maghzal, M.-C. Leck, E. Collinson, C. Li, and R. Stocker Limited Role for the Bilirubin-Biliverdin Redox Amplification Cycle in the Cellular Antioxidant Protection by Biliverdin Reductase J. Biol. Chem., October 23, 2009; 284(43): 29251 - 29259. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Deck, A. Vasanthakumar, S. A. Anderson, J. B. Goforth, M. C. Kennedy, W. E. Antholine, and R. S. Eisenstein Evidence That Phosphorylation of Iron Regulatory Protein 1 at Serine 138 Destabilizes the [4Fe-4S] Cluster in Cytosolic Aconitase by Enhancing 4Fe-3Fe Cycling J. Biol. Chem., May 8, 2009; 284(19): 12701 - 12709. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Zhang, Y.-G. Bai, L.-J. Lin, J.-X. Bao, Y.-Y. Zhang, H. Tang, J.-H. Cheng, G.-L. Jia, X.-L. Ren, and J. Ma Blockade of AT1 receptor partially restores vasoreactivity, NOS expression, and superoxide levels in cerebral and carotid arteries of hindlimb unweighting rats J Appl Physiol, January 1, 2009; 106(1): 251 - 258. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. S. A. Capettini, S. F. Cortes, M. A. Gomes, G. A. B. Silva, J. L. Pesquero, M. J. Lopes, M. M. Teixeira, and V. S. Lemos Neuronal nitric oxide synthase-derived hydrogen peroxide is a major endothelium-dependent relaxing factor Am J Physiol Heart Circ Physiol, December 1, 2008; 295(6): H2503 - H2511. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. D. Fike, J. C. Slaughter, M. R. Kaplowitz, Y. Zhang, and J. L. Aschner Reactive oxygen species from NADPH oxidase contribute to altered pulmonary vascular responses in piglets with chronic hypoxia-induced pulmonary hypertension Am J Physiol Lung Cell Mol Physiol, November 1, 2008; 295(5): L881 - L888. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Korge, P. Ping, and J. N. Weiss Reactive Oxygen Species Production in Energized Cardiac Mitochondria During Hypoxia/Reoxygenation: Modulation by Nitric Oxide Circ. Res., October 10, 2008; 103(8): 873 - 880. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. P. Jones Radical-free biology of oxidative stress Am J Physiol Cell Physiol, October 1, 2008; 295(4): C849 - C868. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. Maghzal, S. R. Thomas, N. H. Hunt, and R. Stocker Cytochrome b5, Not Superoxide Anion Radical, Is a Major Reductant of Indoleamine 2,3-Dioxygenase in Human Cells J. Biol. Chem., May 2, 2008; 283(18): 12014 - 12025. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Pasdois, B. Beauvoit, L. Tariosse, B. Vinassa, S. Bonoron-Adele, and P. D. Santos Effect of diazoxide on flavoprotein oxidation and reactive oxygen species generation during ischemia-reperfusion: a study on Langendorff-perfused rat hearts using optic fibers Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2088 - H2097. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Bogunovic, M. Stojakovic, L. Chen, and M. Maric An Unexpected Functional Link between Lysosomal Thiol Reductase and Mitochondrial Manganese Superoxide Dismutase J. Biol. Chem., April 4, 2008; 283(14): 8855 - 8862. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Quijano, L. Castro, G. Peluffo, V. Valez, and R. Radi Enhanced mitochondrial superoxide in hyperglycemic endothelial cells: direct measurements and formation of hydrogen peroxide and peroxynitrite Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3404 - H3414. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Zhu, S. Alvarez, E. L. Marsh, M. E. LeNoble, I.-J. Cho, M. Sivaguru, S. Chen, H. T. Nguyen, Y. Wu, D. P. Schachtman, et al. Cell Wall Proteome in the Maize Primary Root Elongation Zone. II. Region-Specific Changes in Water Soluble and Lightly Ionically Bound Proteins under Water Deficit Plant Physiology, December 1, 2007; 145(4): 1533 - 1548. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Sanders and J. R. Hoidal The NOX on Pulmonary Hypertension Circ. Res., August 3, 2007; 101(3): 224 - 226. [Full Text] [PDF]
|
|
|
|
 |
|
 C. H. Coyle, S. Mendralla, S. Lanasa, and K. N. Kader Endothelial Cell Seeding onto Various Biomaterials Causes Superoxide-induced Cell Death J Biomater Appl, July 1, 2007; 22(1): 55 - 69. [Abstract] [PDF]
|
|
|
|
|
|
E. Robin, R. D. Guzy, G. Loor, H. Iwase, G. B. Waypa, J. D. Marks, T. L. V. Hoek, and P. T. Schumacker Oxidant Stress during Simulated Ischemia Primes Cardiomyocytes for Cell Death during Reperfusion J. Biol. Chem., June 29, 2007; 282(26): 19133 - 19143. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. White, N. Krishnan, D. F. Becker, and J. J. Tanner Structure and Kinetics of Monofunctional Proline Dehydrogenase from Thermus thermophilus J. Biol. Chem., May 11, 2007; 282(19): 14316 - 14327. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Wells and A. Holian Asymmetric Dimethylarginine Induces Oxidative and Nitrosative Stress in Murine Lung Epithelial Cells Am. J. Respir. Cell Mol. Biol., May 1, 2007; 36(5): 520 - 528. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Bailey, G. Robinson, A. Pinner, L. Chamlee, E. Ulasova, M. Pompilius, G. P. Page, D. Chhieng, N. Jhala, A. Landar, et al. S-adenosylmethionine prevents chronic alcohol-induced mitochondrial dysfunction in the rat liver Am J Physiol Gastrointest Liver Physiol, November 1, 2006; 291(5): G857 - G867. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Robinson, M. S. Janes, M. Pehar, J. S. Monette, M. F. Ross, T. M. Hagen, M. P. Murphy, and J. S. Beckman Selective fluorescent imaging of superoxide in vivo using ethidium-based probes PNAS, October 10, 2006; 103(41): 15038 - 15043. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Drose, U. Brandt, and P. J. Hanley K+-independent Actions of Diazoxide Question the Role of Inner Membrane KATP Channels in Mitochondrial Cytoprotective Signaling J. Biol. Chem., August 18, 2006; 281(33): 23733 - 23739. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Kussmaul and J. Hirst The mechanism of superoxide production by NADH:ubiquinone oxidoreductase (complex I) from bovine heart mitochondria PNAS, May 16, 2006; 103(20): 7607 - 7612. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Anrather, G. Racchumi, and C. Iadecola NF-{kappa}B Regulates Phagocytic NADPH Oxidase by Inducing the Expression of gp91phox J. Biol. Chem., March 3, 2006; 281(9): 5657 - 5667. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Wang, M. Tong, S. Chinta, J. U. Raj, and Y. Gao Hypoxia-induced reactive oxygen species downregulate ETB receptor-mediated contraction of rat pulmonary arteries Am J Physiol Lung Cell Mol Physiol, March 1, 2006; 290(3): L570 - L578. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. A. Hatoum, M. F. Otterson, D. Kopelman, H. Miura, I. Sukhotnik, B. T. Larsen, R. M. Selle, J. E. Moulder, and D. D. Gutterman Radiation Induces Endothelial Dysfunction in Murine Intestinal Arterioles via Enhanced Production of Reactive Oxygen Species Arterioscler Thromb Vasc Biol, February 1, 2006; 26(2): 287 - 294. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. He, B. Dinger, K. Sanders, J. Hoidal, A. Obeso, L. Stensaas, S. Fidone, and C. Gonzalez Effect of p47phox gene deletion on ROS production and oxygen sensing in mouse carotid body chemoreceptor cells Am J Physiol Lung Cell Mol Physiol, December 1, 2005; 289(6): L916 - L924. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Zagorac, K. Yamaura, C. Zhang, R. J. Roman, and D. R. Harder The Effect of Superoxide Anion on Autoregulation of Cerebral Blood Flow Stroke, December 1, 2005; 36(12): 2589 - 2594. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Umbach, F. Fiorani, and J. N. Siedow Characterization of Transformed Arabidopsis with Altered Alternative Oxidase Levels and Analysis of Effects on Reactive Oxygen Species in Tissue Plant Physiology, December 1, 2005; 139(4): 1806 - 1820. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ohashi, F. Faraci, and D. Heistad Peroxynitrite hyperpolarizes smooth muscle and relaxes internal carotid artery in rabbit via ATP-sensitive K+ channels Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2244 - H2250. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Suvorava, N. Lauer, S. Kumpf, R. Jacob, W. Meyer, and G. Kojda Endogenous Vascular Hydrogen Peroxide Regulates Arteriolar Tension In Vivo Circulation, October 18, 2005; 112(16): 2487 - 2495. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Frisbee Reduced nitric oxide bioavailability contributes to skeletal muscle microvessel rarefaction in the metabolic syndrome Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2005; 289(2): R307 - R316. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W. Zmijewski, D. R. Moellering, C. L. Goffe, A. Landar, A. Ramachandran, and V. M. Darley-Usmar Oxidized LDL induces mitochondrially associated reactive oxygen/nitrogen species formation in endothelial cells Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H852 - H861. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Satoh, S. Fujimoto, Y. Haruna, S. Arakawa, H. Horike, N. Komai, T. Sasaki, K. Tsujioka, H. Makino, and N. Kashihara NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy Am J Physiol Renal Physiol, June 1, 2005; 288(6): F1144 - F1152. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. T. Teoh, P. V. Turner, and D. H. Evans Tumorigenic Poxviruses Up-Regulate Intracellular Superoxide To Inhibit Apoptosis and Promote Cell Proliferation J. Virol., May 1, 2005; 79(9): 5799 - 5811. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Simoncini, C. Sapet, L. Camoin-Jau, N. Bardin, J.-R. Harle, J. Sampol, F. Dignat-George, and F. Anfosso Role of reactive oxygen species and p38 MAPK in the induction of the pro-adhesive endothelial state mediated by IgG from patients with anti-phospholipid syndrome Int. Immunol., April 1, 2005; 17(4): 489 - 500. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Phillips, F. A. Sylvester, and J. C. Frisbee Oxidant stress and constrictor reactivity impair cerebral artery dilation in obese Zucker rats Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2005; 288(2): R522 - R530. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. P. Didion and F. M. Faraci Ceramide-Induced Impairment of Endothelial Function Is Prevented by CuZn Superoxide Dismutase Overexpression Arterioscler Thromb Vasc Biol, January 1, 2005; 25(1): 90 - 95. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. A. Hatoum, D. G. Binion, H. Miura, G. Telford, M. F. Otterson, and D. D. Gutterman Role of hydrogen peroxide in ACh-induced dilation of human submucosal intestinal microvessels Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H48 - H54. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F.-X. Yi, R. R. Magness, and I. M. Bird Simultaneous imaging of [Ca2+]i and intracellular NO production in freshly isolated uterine artery endothelial cells: effects of ovarian cycle and pregnancy Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2005; 288(1): R140 - R148. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Lauer, T. Suvorava, U. Ruther, R. Jacob, W. Meyer, D. G. Harrison, and G. Kojda Critical involvement of hydrogen peroxide in exercise-induced up-regulation of endothelial NO synthase Cardiovasc Res, January 1, 2005; 65(1): 254 - 262. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. IJdo and A. C. Mueller Neutrophil NADPH Oxidase Is Reduced at the Anaplasma phagocytophilum Phagosome Infect. Immun., September 1, 2004; 72(9): 5392 - 5401. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Warner, H. Sheng, and I. Batinic-Haberle Oxidants, antioxidants and the ischemic brain J. Exp. Biol., August 15, 2004; 207(18): 3221 - 3231. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Carlyon, D. A. Latif, M. Pypaert, P. Lacy, and E. Fikrig Anaplasma phagocytophilum Utilizes Multiple Host Evasion Mechanisms To Thwart NADPH Oxidase-Mediated Killing during Neutrophil Infection Infect. Immun., August 1, 2004; 72(8): 4772 - 4783. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-Y. Chyu, P. C Dimayuga, X. Zhao, J. Nilsson, P. K Shah, and B. Cercek Altered AP-1/Ref-1 redox pathway and reduced proliferative response in iNOS-deficient vascular smooth muscle cells Vascular Medicine, August 1, 2004; 9(3): 177 - 183. [Abstract] [PDF]
|
|
|
|
 |
|
 K. Egi, N. E. Conrad, J. Kwan, C. Schulze, R. Schulz, and S. M. Wildhirt Inhibition of inducible nitric oxide synthase and superoxide production reduces matrix metalloproteinase-9 activity and restores coronary vasomotor function in rat cardiac allografts Eur. J. Cardiothorac. Surg., August 1, 2004; 26(2): 262 - 269. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. S. Jose, M. U. Moreno, S. Olivan, O. Beloqui, A. Fortuno, J. Diez, and G. Zalba Functional Effect of the p22phox -930A/G Polymorphism on p22phox Expression and NADPH Oxidase Activity in Hypertension Hypertension, August 1, 2004; 44(2): 163 - 169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. E. Wyche, S. S. Wang, K. K. Griendling, S. I. Dikalov, H. Austin, S. Rao, B. Fink, D. G. Harrison, and A. M. Zafari C242T CYBA Polymorphism of the NADPH Oxidase Is Associated With Reduced Respiratory Burst in Human Neutrophils Hypertension, June 1, 2004; 43(6): 1246 - 1251. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Raffo, J. C. Lai, C. A. Stein, P. Miller, S. Scaringe, A. Khvorova, and L. Benimetskaya Antisense RNA Down-Regulation of bcl-2 Expression in DU145 Prostate Cancer Cells Does Not Diminish the Cytostatic Effects of G3139 (Oblimersen) Clin. Cancer Res., May 1, 2004; 10(9): 3195 - 3206. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Nadruz Jr, V. J. Lagosta, H. Moreno Jr, O. R. Coelho, and K. G. Franchini Simvastatin Prevents Load-Induced Protein Tyrosine Nitration in Overloaded Hearts Hypertension, May 1, 2004; 43(5): 1060 - 1066. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Gao, J. Chen, S. V. Brodsky, H. Huang, S. Adler, J. H. Lee, N. Dhadwal, L. Cohen-Gould, S. S. Gross, and M. S. Goligorsky Docking of Endothelial Nitric Oxide Synthase (eNOS) to the Mitochondrial Outer Membrane: A PENTABASIC AMINO ACID SEQUENCE IN THE AUTOINHIBITORY DOMAIN OF eNOS TARGETS A PROTEINASE K-CLEAVABLE PEPTIDE ON THE CYTOPLASMIC FACE OF MITOCHONDRIA J. Biol. Chem., April 16, 2004; 279(16): 15968 - 15974. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Tarpey, D. A. Wink, and M. B. Grisham Methods for detection of reactive metabolites of oxygen and nitrogen: in vitro and in vivo considerations Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2004; 286(3): R431 - R444. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Teufelhofer, R.-M. Weiss, W. Parzefall, R. Schulte-Hermann, M. Micksche, W. Berger, and L. Elbling Promyelocytic HL60 Cells Express NADPH Oxidase and Are Excellent Targets in a Rapid Spectrophotometric Microplate Assay for Extracellular Superoxide Toxicol. Sci., December 1, 2003; 76(2): 376 - 383. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sato, I. Sakuma, and D. D. Gutterman Mechanism of dilation to reactive oxygen species in human coronary arterioles Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2345 - H2354. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-L. M Cooke and S. T Davidge Endothelial-dependent vasodilation is reduced in mesenteric arteries from superoxide dismutase knockout mice Cardiovasc Res, December 1, 2003; 60(3): 635 - 642. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. F Turrens Mitochondrial formation of reactive oxygen species J. Physiol., October 15, 2003; 552(2): 335 - 344. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Lai, L. Benimetskaya, R. M. Santella, Q. Wang, P. S. Miller, and C. A. Stein G3139 (oblimersen) may inhibit prostate cancer cell growth in a partially bis-CpG-dependent non-antisense manner Mol. Cancer Ther., October 1, 2003; 2(10): 1031 - 1043. [Abstract] [Full Text]
|
|
|
|
|
|
C. S. Powell and R. M. Jackson Mitochondrial complex I, aconitase, and succinate dehydrogenase during hypoxia-reoxygenation: modulation of enzyme activities by MnSOD Am J Physiol Lung Cell Mol Physiol, July 1, 2003; 285(1): L189 - L198. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X.-L. Chen, Q. Zhang, R. Zhao, X. Ding, P. E. Tummala, and R. M. Medford Rac1 and Superoxide Are Required for the Expression of Cell Adhesion Molecules Induced by Tumor Necrosis Factor-alpha in Endothelial Cells J. Pharmacol. Exp. Ther., May 1, 2003; 305(2): 573 - 580. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. Reckelhoff and J. C. Romero Role of oxidative stress in angiotensin-induced hypertension Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2003; 284(4): R893 - R912. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-Y. Sohn, F. Krotz, S. Zahler, T. Gloe, M. Keller, K. Theisen, T. M Schiele, V. Klauss, and U. Pohl Crucial role of local peroxynitrite formation in neutrophil-induced endothelial cell activation Cardiovasc Res, March 1, 2003; 57(3): 804 - 815. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Werner Determination of Cellular H2O2 Production Sci. Signal., February 4, 2003; 2003(168): pl3 - pl3. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Pignatelli, L. Lenti, V. Sanguigni, G. Frati, I. Simeoni, P. P. Gazzaniga, F. M. Pulcinelli, and F. Violi Carnitine inhibits arachidonic acid turnover, platelet function, and oxidative stress Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H41 - H48. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. D. Glickman Phototoxicity to the Retina: Mechanisms of Damage International Journal of Toxicology, November 1, 2002; 21(6): 473 - 490. [Abstract] [PDF]
|
|
|
|
|
|
D. W. Stepp, J. Ou, A. W. Ackerman, S. Welak, D. Klick, and K. A. Pritchard Jr. Native LDL and minimally oxidized LDL differentially regulate superoxide anion in vascular endothelium in situ Am J Physiol Heart Circ Physiol, August 1, 2002; 283(2): H750 - H759. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kotamraju, C. R. Chitambar, S. V. Kalivendi, J. Joseph, and B. Kalyanaraman Transferrin Receptor-dependent Iron Uptake Is Responsible for Doxorubicin-mediated Apoptosis in Endothelial Cells. ROLE OF OXIDANT-INDUCED IRON SIGNALING IN APOPTOSIS J. Biol. Chem., May 3, 2002; 277(19): 17179 - 17187. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Tsikas, E. Schwedhelm, and J. C. Frolich Methodological Considerations on the Detection of 3-Nitrotyrosine in the Cardiovascular System Circ. Res., April 5, 2002; 90 (6): e70 - e70. [Full Text] [PDF]
|
|
|
|
|
|
R. Locher, R. P. Brandes, W. Vetter, and M. Barton Native LDL Induces Proliferation of Human Vascular Smooth Muscle Cells via Redox-Mediated Activation of ERK 1/2 Mitogen-Activated Protein Kinases Hypertension, February 1, 2002; 39(2): 645 - 650. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. B. Afanas'ev Lucigenin Chemiluminescence Assay for Superoxide Detection Circ. Res., November 23, 2001; 89 (11): e46 - e46. [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||